MOH Pocket Manual in Emergency Medicine

MOH Pocket Manual in
Emergency
MOH Pocket Manual in Emergency
COntent
cardiac emergency
Contents
Chapter 1: Cardiac emergency:
Acute ST Elevation Myocardial Infarction1 .
Non ST Elevation Myocardial Infarction.
Atrial fibrillation.
Bradydysrhythmias.
Hypertension.
Acute Aortic Syndromes.
Deep Venous Thrombosis.
Chapter 2: Pulmonary emergency:
Acute bronchial Asthma.
Chapter 3 : Neurological emergency:
Headache.
Adult Acute Bacterial Meningitis.
Chapter 4 :Toxicology:
Acetaminophen (Paracetamol, APAP) Overdose.
Carbon Monoxide Poisoning.
Chapter 5 : Hematological emergency:
Sickle cell disease in emergency department.
Anticoagulation Emergencies.
Chapter 6 : Endocrinology and electrolyte emergency:
Hypokalemic and Hyperkalemia Emergencies.
Diabetic emergency.
4
conten t
Thyroid Storm and Myxedema Coma

Chapter 7 : Urological emergency:
Rhabdomyolysis.
Acute Urinary Retention.
Chapter 8 : Trauma and environmental:
Severe Traumatic Brain Injury.
Electrical Injuries.
Heat injury.
Chapter 9 : Medications List
con t en t
cardiac emergency
Chapter
1
CRADIAC
EMERGENCY
cardiac emergency
Acute ST Elevation and Non

ST Elevation Myocardial Infarction
Overview
Acute coronary syndrome involves:
1.
ST elevation acute myocardial infarction
2.
NonST-segment elevation acute myocardial infarction
3.
Unstable angina (UA).
Acute ST elevation myocardial infarction typically occurs when

a clot leads to complete occlusion of a coronary artery with trans
mural , or full thickness myocardial infarction .
The ECG will show ST segment elevation in the involved area
of the heart.
NonST-segment elevation acute coronary syndromes (NSTEACS) refers to a disease process characterized by reduced
coronary blood flow resulting in coronary ischemia without STsegment elevations on an electrocardiogram (ECG).
NSTE-ACS include both nonST-segment elevation acute myocardial infarction (MI), as defined by positive biomarkers for MI,
and unstable angina (UA), as defined by negative biomarkers.
cardiac emergency
Clinical Presentation
o History
Chest pain, when it started, what it feels like
(stabbing, crushing, pressure, aching), and if
it radiates to other parts of the body.

Jaw/shoulder/ neck/arm pain.
Dizziness, nausea.
Shortness of breath.
o Physical Examination
Hemodynamic stability, signs of heart failure/left ventricular dysfunction.
Exclusion of noncardiac and nonischemic cardiac

causes requires a thorough examination of the patients chest wallincluding inspection and palpationas well as careful examination of cardiac
and pulmonary functions.
cardiac emergency
Differential diagnosis
o Heart
Acute coronary syndrome
Pericarditis
Myocarditis
Endocarditis
Valvular disease
o Lungs
Pulmonary embolus
Pneumothorax
Pneumonia
Empyema
Hemothorax
COPD
o Esophagus
Esophagitis
GERD
Spasm
Foreign body
Rupture (Boerhaaves)
Esophegeal Tear
o Work up
CBC.
Electrolytes.
Coagulation studies.
Cardiac enzymes.
ECG.
Cardiac biomarkers.
10
cardiac emergency
Management
o Prehospital Care:
Three goals:
(1) Delivering patients to an appropriate health care facility as
quickly as possible.
(2) Preventing sudden death and controlling arrhythmias by using
acute cardiac life support (ACLS) protocol when necessary.
(3) Initiating or continuing management of patients during interfacility transport.

Checklist to get from the EMS team includes the following information:
1. The person who initiated EMS involvement (patient, family,

bystander, transferring hospital) and why.
2. Complaints at the scene.
3. Initial vital signs and physical examination results, as well as
notable changes.
4. Therapies given prior to arrival and the patients response.
5. ECGs done at an outside hospital or en route, noting the context
in which notable ECGs were printed.
cardiac emergency
11
6. The patients code status (if known).

7. Family contacts for supplemental information and family members who may be on their way to the ED, as they may be helpful in completing or verifying the history.
In hospital care for STEMI:
12
Assess and stabilize airway, breathing, and circulation.
Do ECG.
Provide oxygen; attach cardiac and oxygen saturation

monitors; establish IV access.
Treat arrhythmia rapidly according to ACLS protocols.
Give aspirin 162 to 325 mg (non-enteric coated), to be

chewed and swallowed (allergy to aspirin is an absolute contraindication) .
Give three sublingual nitroglycerin tablets (0.4 mg) one

at a time, spaced five minutes apart ifpatient has persistent chest discomfort, hypertension, or signs of heart
failureandthere is no sign of hemodynamic compromise and no use of phosphodiesterase inhibitors, inferior MI with right ventricular extension.
Give morphine sulfate (2 to 4 mg slow IV push every 5

to 15 minutes) for persistent discomfort or anxiety.
cardiac emergency
Select reperfusion strategy:

Primary percutaneous coronary intervention (PCI)

strongly preferred, especially for patients with cardiogenic shock, heart failure, late presentation, or contraindications to fibrinolysis.
Treat with fibrinolysis if PCI unavailable within 90-120

minutes, symptoms <12 hours, and no contraindications
Give antiplatelet therapy (in addition to aspirin) to all

patients:
Patients treated with fibrinolytic therapy:
Give clopidogrel loading dose 300 mg if age
less than 75 years; if age 75 years or older,
give loading dose of 75 mg.
Give anticoagulant therapy to all patients:
Unfractionated heparin:
-For patients undergoing primary PCI, we suggest an initial intravenous (IV) bolus of 50 to 70 units/kg up to a maximum of
5000 units.
-For patients treated with fibrinolysis, we suggest an IV bolus of
60 to 100 units/kg up to a maximum of 4000 units and for patients treated with medical therapy (no reperfusion) an IV bolus
cardiac emergency
13
of 50 to 70 units/kg up to a maximum of 5000 units.

-Both should be followed by an IV drip of 12 units/kg per hour
(goal aPTT time of 1.5 to 2 times control or approximately 50
to 75 seconds).
Disposition
Admit to ICU
In hospital care for NSTEMI:

o Management
High-risk patient:
:Early invasive1. Discuss with cardiology.

2. Clopidogrel 300 mg or GPIIb/IIIa inhibitor.
3. Prompt PCI.
Not high-risk patient:
-Early conservative:
Clopidogrel 300 mg.
14
cardiac emergency
Disposition
Admit to ICU.
o Alert
Sudden onset of severe pain.
Occurring during exercise.
Lasting longer than 15 minutes.
Associated with shortness of breath.
Nausea/vomiting and sweating.
Radiation to left arm or jaw.
In case of inferior myocardial infarction , you must do

Right side and Posterior ECGs to rule out Right ventricular or Posterior MI .
cardiac emergency
15
Atrial Fibrillation: Management Strategies

Overview
o Cardiac causes:
Mitral valve disease.

Myocardial disease.
Conduction system disorders.
Wolff-Parkinson-White syndrome.
Pericardial disease.
Conditions associated with AF include:
16
Thyrotoxicosis.
Hypothermia.
Alcohol use.
Severe infection.
Hypoxia.
Pulmonary emboli.
Pneumonia.
Kidney disease.
Obesity.
Diabetes mellitus.
Digoxin toxicity.
Electrolyte abnormalities.
Intrathoracic surgery, such as cardiac or pulmonary

surgery, or invasive cardiac studies.
cardiac emergency
Atrial Fibrillation is categorized as follows:

First detected episode.
Recurrent (after two or more episodes).
Paroxysmal (if recurrent AF terminates spontaneously).
Persistent (if sustained beyond 7 days).
o History
Anxiety, palpitations, shortness of breath,
dizziness, chest pain, or generalized fatigue.

Medications and alcohol and drug use.
Physical Examination

Vital signs.
Oxygen saturation.
Evidence of thyroid disease (eg, exophthalmos and enlarged thyroid).
Evidence of deep vein thrombosis/pulmonary embolus

(e.g., unilateral lower extremity swelling or tenderness).
The cardiac evaluation: rate, rhythm, and the presence

of heart murmurs.
cardiac emergency
17
Rhythm
Atrial
Frequency,
beats/min
Ventricular
Frequency,
beats/min
P-wave
Sinus
tachycardia
100-180
100-180
Precedes every
QRS complex
Atrial
fibrillation
400-600
irregu ,60-1900
larly irregular
Absent
Atrial
flutter
250-350
regu ,75-1500
lar, sometimes
alternating
block
Sawtooth
Atrioventricular
nodal
reentrant
tachycardia
180-250
180-250
In QRS complex
)(R
75-250
Precedes QRS;
P-wave differs
from sinus Pwave
100 >
or more dif 3
ferent P-wave
morphologies at
different rates
Atrial
tachycardia
Multifocal atrial
tachycardia
18
120-250
100 >
cardiac emergency
Atrial
fibrillation with
WolffParkinsonWhite
syndrome
400-600
with ,180-300
wide, bizarre
QRS complexes
Absent
Work up

Electrocardiogram.
Complete blood cell count.
Metabolic panel.
Hepatic function panel.
A thyroid panel.
Chest radiography.
cardiac emergency
19
Management
o Prehospital Care:
Cardioversion considered if the patient exhibits signs
of hemodynamic compromise or poor coronary artery
perfusion.
o In hospital care:
Unstable Patients: as :
-
Altered mental status.
Ischemic chest discomfort.
Acute heart failure.
Hypotension.
Signs of shock or hemodynamic compromise.
o Immediate direct current cardioversion:

200 J biphasic.

200-360 J monophasic.
Can consider lower energy for atrial flutter.
Anticipate failure.
20
cardiac emergency
o If no success repeats direct current cardioversion:

Increase energy level.

Consider anterior-posterior pad placement for biphasic

defibrillators.
Time with patients respiratory cycle, shock during full

expiration.
Stable Patients:
If Suspicion for accessory pathway?
Wide, bizarre QRS complexes.
Ventricular rate > 250 bpm.
History of Wolff-Parkinson-White syndrome.
Prior ECG with delta wave.
o Give: Amiodarone.
If No suspicious of accessory pathway:

Diltiazem < 0.2 mg/kg slow IV bolus or 2.5 mg/min

drip up to 50 mg total.
Amiodarone: 150 mg over the FIRST 10 minutes (15
Or
cardiac emergency
21
mg/min) followed by 360 mg over the NEXT 6 hours

(1 mg/min) then 540 mg over the REMAINING 18
hours (0.5 mg/min).

Beta blockers as :
Esmolol 0.5 mg/kg over one min loading dose then 0.06-0.2 mg
/ kg/ min
Metoprolol 2.5 -5 mg bolus over 2 min , up to 3 doses.
o Disposition
22
Admission of new-onset AF only for patients with decompensated heart failure or myocardial ischemia or
for patients who are highly symptomatic and in whom
adequate rate control cannot be achieved.
Follow your hospital policy of admission .
cardiac emergency
o Alert

Palpitations during exertion or palpitations with

associated syncope or pre-syncope.
ECG abnormalities.
Family history of sudden cardiac death or with

a first-degree relative affected by an inheritable
heart condition.
Cardioversion needs procedural sedation and analgesia.
cardiac emergency
23
Bradydysrhythmias
Overview
Categories of Bradydysrhythmias
Bradydysrhythmia
Category
Bradydysrhythmia Type
Sinus node dysfunc-

tion

AV blocks
24
cardiac emergency
Sinus bradycardia
Sinus arrest
Tachy-brady syndrome
Chronotropic incompetence
First-degree AV block
Second-degree AV block (Mobitz type I or

Wenckebach)
Second-degree AV block (Mobitz type II)
Third-degree AV block (complete heart block)
History
Assessing the History of the Patient with Bradydysrhythmia
History
Possible Underlying Pathology
Preceding angina symptoms
Myocardial ischemia/infarction
Fevers, travel to endemic areas, tick bite
Infectious agent
Cold intolerance, weight

gain, increased fatigue
Hypothyroidism
Headache, mental status

change, recent head
trauma, falls
Intracranial causes, including intracranial hemorrhage
Abdominal pain or
distention
Intra-abdominal hemorrhage
Recent additions or
changes to medications
Drug toxicity
History of end-stage
renal disease, receiving
dialysis
Hyperkalemia
cardiac emergency
25
Cancer history, receiving

treatment
Acute or long-term toxicity from

chemotherapeutic agents
Severe pain, anxiety,

strong emotion preceding the event
Vasovagal reflex, neurocardiogenic

Perfusion can be confirmed with the identification of

strong peripheral pulses, brisk capillary refill, and warm
extremities.
Evidence of heart failure may be suggested by lowerextremity edema, elevated jugular venous distention, or
rales in the lower lung fields.
o Differential diagnosis
26
cardiac emergency
Category
Disease Process
Ischemia and
infarction
Inferior myocardial infarction, especially involving the right coronary

artery
Neurocardiogen
ic or reflex-mediated
Vasovagal reflex
Hypersensitive carotid sinus syndrome
Intra-abdominal hemorrhage
Increased intracranial pressure
Metabolic, en
docrine, and environmental
Hypothyroidism
Infectious and
postinfectious
Chagas disease (Trypanosoma cruzi)
Hyperkalemia
Hypothermia
Lyme disease (Borrelia species)
Viral agents (parvovirus B19, coxsackievirus B, etc)
Syphilis (Treponema pallidum)
Toxicologic
Therapeutic doses of prescribed

drugs, overdoses of drugs, or
poisoning
cardiac emergency
27
Work up

Electrolyte levels, especially potassium.
A drug level should be obtained on all patients who are currently taking digoxin.
Thyroid function testing.
Cardiac biomarkers.
CT of the head.
Chest x-ray.
Management
o Prehospital Care:
28
Maintain patent airway; assist breathing as necessary.
Oxygen (if hypoxemic).
Cardiac monitor to identify rhythm.
Monitor blood pressure and oximetry.
IV access.
12-lead ECG, if available.
cardiac emergency
Looking for evidence of hemodynamic instability,

including hypotension and altered mentation.
Treated in the field and en route to the ED by protocols

and procedures based on the Advanced Cardiac Life
Support (ACLS) algorithm.
In hospital:
o The Unstable Patient:

Airway control, oxygen administration, and ventilatory

assistance.
Atropine administration remains the first-line medication for unstable and symptomatic patients with
bradydysrhythmias:
-The recommended dose is 0.5 mg intravenously every 3 to 5 minutes, with a maximum dose of 3 mg.

If atropine administration has been ineffective, a betaadrenergic agent (such as dopamine, epinephrine, or
isoproterenol) should be considered.
- Dopamine infusion should be initiated at 2 to 10 mcg/kg/min in

patients who have failed to improve with atropine.
Or
- Epinephrine I V infusion 2 to 10 mcg/min .
cardiac emergency
29
Pacing should be initiated in unstable patients who have

not responded to atropine or beta-adrenergic agents.
The Stable Patient:

Identify the underlying etiology of the bradydysrhythmia.
Drug or Toxin
Beta blockers
Specific Antidotes and Therapies for Toxicological Causes of BradydysrhythmiasAntidote or Therapy

Glucagon: 5 mg IV; can be repeated every 10
min, up to 3 doses
Calcium gluconate 10%, 30 to 60 cc IV -
Calcium channel blockers
Insulin (regular): 1 unit/kg bolus

units/kg/h infusion; supplement
as needed
+ 0.5 glucose
Digitalis (di)goxin
Digoxin immune Fab (Digibind or DigiFab): empirically, 10-20 vials (if serum digoxin level is available, product insert can be
)used for more exact dosing guide
Opioids
Naloxone: 0.4 mg IV, then 2 mg IV if no response
Organophosphates
30
Atropine: 2 mg IV; double every 3-5 min until

pulmonary secretions are manageable
Pralidoxime (2-PAM): 2 g IV over 10-15 min,
repeated every 6 h
cardiac emergency
Disposition

Symptomatic bradydysrhythmias are admitted.
Unstable patient admitted to ICU.
Hypertension
Overview
Definitions of Hypertension
Hypertensive emergency
Blood pressure > 140/90 mm Hg with impending or progressive
Target organ dysfunction
Hypertensive urgency
Blood pressure > 180/120 mm Hg without impending or progressive
Target organ dysfunction
Hypertensive crisis
A hypertensive emergency or urgency
Mean arterial pressure
Average blood pressure reading over 1 cardiac cycle; can be
cardiac emergency
31
calculated
As [systolic blood pressure + (2 x diastolic blood pressure)] 3
Essential hypertension
Hypertension without a specific secondary cause
Secondary hypertension
Hypertension related to an underlying pathologic process, e.g.,
adrenal disease; renal disease; or drug effects, interactions, or
withdrawal.
History
Key Questions Regarding History of the Present Illness
Question Comments/Concerns
- Have you ever been told you have high blood pressure?
Open-ended, inclusive question; many people do not think they
have high blood pressure if they are takingor have in the past
takenmedication for it.
- Do you have any chest pain?
Myocardial infarction, aortic dissection
32
cardiac emergency
- Do you have any shortness of breath?

Myocardial infarction, aortic dissection, pulmonary edema, heart
failure
- Are you on any medications, or are you using any recreational
drugs or herbal medicines? Neuroleptic malignant syndrome;
serotonin syndrome; cocaine, phencyclidine, or other sympathomimetic.
- Have you recently stopped taking any medications or recreational drugs or herbal medicines?
Delirium tremens, clonidine and other drug withdrawal
- Have you had any focal weakness, slurring of speech, numbness,
or clumsiness?
Stroke, transient ischemic attack, intracranial hemorrhage
- Do you snore or wake up during sleep? Do you feel tired
throughout the day? Obstructive sleep apnea
- Have you had high blood pressure in the past that has not responded to multiple medications?
cardiac emergency
33

Vital signs should be checked and rechecked,

including pulses and BPs in all extremities.
A funduscopic examination.
Checking the thyroid and reflexes.
A complete cardiopulmonary examination is

critical for establishing the patients baseline,
and an abdominal examination should assess
for evidence of an aortic aneurysm.
The neurologic examination.
Differential Diagnosis
34
Stroke.
Aortic dissection.
Drug intoxication: cocaine, amphetamine,

monoamine oxidase inhibitor.
Drug withdrawal: antihypertensive, alcohol,

sedative hypnotics.
Renal failure.
Pheochromocytoma or other.
cardiac emergency
Tumor.
Thyroid storm.
Work up

Complete blood cell count.
Serum chemistry.
Electrocardiogram.
Chest radiograph.
Urine drug screen.
Urinalysis.
Pregnancy test.
o Management
o Prehospital Care

Evaluated for signs or symptoms of endorgan damage.
History, including the medications.
cardiac emergency
35
In hospital care:
Asymptomatic Patients with BP Less Than 180/110 mm Hg:
-Patients with BP measurements less than 180/110 mm Hg with
no signs of End organ damage ,do not need to be treated in the
ED
-Instead, these patients should follow up with a primary care
provider within 1 week.
Patients with BP Over 180/110 mm Hg and a History Of
Hypertension on Antihypertensive Medications:
-If these patients have missed their medications, they may be
restarted on the drugs.
-Efforts should be made to ensure that the barriers that prevented
the patient from taking the medications are addressed.
-For those patients who are compliant with their medications but
still have an elevated BP, adjustments must be made.
Asymptomatic Patients with BP Over 180/110 mm Hg and No
History of Hypertension:
-In this scenario, patients should be started on antihypertensive
medication ( no need to aggressive lowering of BP ) , and regular follow-up in OPD clinic .
36
cardiac emergency
Parenteral Drugs for Treatment of Hypertensive

Emergencies:
Drug
Dose
Onset of
Action
Duration of
Adverse
Effects
Special
Indications
Nausea,
vomiting,
muscle
twitching,
sweating,
thiocynate
Most
hypertensive
emergencies;
and
cyanide
intoxication. May
caution
with
high
increase
intracranial pressure
intracranial
pressure
or
Action
Vasodilators
Sodium 0.25-10
nitrog/kg/
prusside min as
IV infusion
Immediate
1-2 min
azotemia
cardiac emergency
37
Nicardipine
hydrochloride
5-15
mg/h
IV
5-10 min
( not
in the
MOH
formulary )
15-30
min,
may
Tachycardia,
headache,
flushing,
Most
hypertensive
emerexceed 4
hrs
local phle- gencies
bitis
except
acute
heart
failure;
caution
with
coronary
ischemia
0.1-0.3
g/kg/
min IV
< 5 min
infusion
30 min
Tachycardia,
headache,
nausea,
flushing
Most
hypertensive
emergencies;
caution
with
glaucoma
38
cardiac emergency
Nitroglycerin
5-100
g/min
as IV
2-5 min
5-10
min
Headache,
vomiting,
methemoglobinemia,
infusion
Coronary
ischemia
tolerance
with
prolonged
use
Enalaprilat
( not
in the
MOH
formulary )
1.255
mg
every 6
hrs IV
15-30
min
6-12 hrs
Precipitous fall in
pressure in
high-renin
states;
variable
response
Acute
left
ventricular
failure;
avoid
in
acute
myocardial
infarction
cardiac emergency
39
Hydralazine
hydrochloride
10-20
mg IV
10-20
min IV
1-4 hrs
IV
10-40
mg IM
2030
min IM
4-6 hrs
IM
Tachycardia,
flushing,
headache,
Eclampsia
vomiting,
aggravation of
angina
Adrenergic Inhibitors
Labetalol
hydrochloride
20-80
mg IV
bolus
5-10 min
every
10 min
0.5-2.0
mg/min
IV
infusion
3-6 hrs
Vomiting, scalp
tingling,
bronchoconstriction,
dizziness,
nausea,
heart
block, orthostatic
hypotension
40
cardiac emergency
Most
hypertensive
emergencies
except
acute
heart
failure
Esmolol
hydrochloride
250
500 g/
kg/
1-2 min
10-30
min
min IV
bolus,
then
Hypotension,
nausea,
asthma,
first-degree heart
block,
heart
50100
g/kg/
min by
Aortic
dissection,
perioperative
failure
infusion;
may
repeat
bolus
after 5
min or
increase
infusion to
300 g/
min
Phentolamine
515
mg IV
bolus
1-2 min
10-30
min
Tachycardia,
flushing,
headache
cardiac emergency
Catecholamine
excess
41
Outpatient Oral Medications for Hypertension Management:

Agent
Starting
Dose
Maximum
Useful Dosage
Indication
Contraindication
Thiazide
12.5 mg
daily
25 mg daily
Drug of
choice for
Gout, , hypokalemia,
uncomplicated
hypertension1;
hypercalcemia
diuretics
(eg,
hydrochlorothiazide)
works well
with other
agents
ACE
inhibitor
5-10 mg
daily
(eg, fosinopril,
lisinopril)
40 mg daily
Patients
with CHF,
diabetes,
previous
MI with
low ejection
fraction
42
cardiac emergency
Bilateral
renal artery
stenosis; hypovolemia

Angiotensin
receptor
blockers
(eg,
losartan)
25-50 mg
daily
100mg daily
Similar
efficacy to
ACE
inhibitors;
used for
Bilateral
renal artery
stenosis; hypovolemia
patients
who cannot
tolerate these
inhibitors
or in addition to
them
cardiac emergency
43

-Blockers
(eg,
25-50 mg
bid
metoprolol)
200 mg bid
Patients
with coronary
artery
disease;
longterm
management
of CHF;
rate control;
hyperthyroidism
Not a good
monotherapy
for lone
hypertension;
heart block;
bradycardia;
sick sinus
syndrome;
bronchospasm;
acute decompensated
CHF exacerbation
44
cardiac emergency

Calcium
channel
180-240
mg
360-540 mg
daily
blockers
Daily
(formulation
dependent)
(eg, diltiazem)
Rate
control or
coronary
artery
disease in
patients
who cannot
take
-blockers
Not a good
monotherapy
for lone
hypertension;
long-acting
agents are
safer than
short-acting
agents; heart
block;
bradycardia;
acute
decompensated CHF
exacerbation;
sick sinus
syndrome
a-2 Agonist (eg,

clonidine)
0.1 mg
bid
0.3 mg tid
Hypertension
resistant
Poor adherence to medical
to other
modalities
regimen
cardiac emergency
45

Hydralazine
10 mg 4
qid
(unknown
mechanism of
vasodilation)
100 mg tid
Hypertension associated
with pregnancy;
hypertension associated
with CHF
in African
Americans
resistant to
other
modalities
46
cardiac emergency
Coronary artery disease
Disposition

If the BP is greater than 200/120 mm Hg ,oral antihypertensive therapy should be started. For BP
greater than 180/110, follow-up should occur within 1 week. If prompt follow-up cannot be ensured,
then further consideration for BP treatment or titration of existing BP medications should be given.
For BP greater than 140/90 mm Hg, follow-up within

one week is recommended.
Patients with hypertensive emergencies admitted to the

intensive care unit after receiving titratable IV antihypertensive agents.
cardiac emergency
47
Acute aortic emergency

Overview
Acute aortic syndrome is defined as three related conditions:
(1) Aortic dissection.
(2) Intramural hematoma.
(3) Penetrating atherosclerotic ulcer.
Aortic dissection is defined as:

Acute if it occurs within 2 weeks of the onset of

symptoms.
Subacute if it occurs between 2 and 6 weeks.
Chronic if it occurs more than 6 weeks from the

onset of pain. (Some authors describe aortic dissections > 2 weeks as chronic).
Two main anatomic classification systems for aortic dissections

:that are defined based on the involvement of the proximal aorta
(1) The DeBakey classification.
(2) The Stanford classification.
48
cardiac emergency
In the DeBakey classification, there are 3 types.

Type I originates in the ascending aorta and extends

into the aortic arch and descending aorta.
Type II is confined only to the ascending aorta.
Type III originates in the descending thoracic aorta and

is further subdivided into
type IIIa, which is limited to the descending thoracic

aorta.
type IIIb, which extends below the diaphragm.
The proximal aorta is defined as the aorta proximal to the brachiocephalic artery; the descending aorta is defined as the aorta distal
to the left subclavian artery.
In the Stanford classification system, aortic dissection is defined

.according to whether the ascending aorta is involved or not

Stanford type A dissections involve the ascending

aorta (similar to DeBakey type I and II).
Stanford type B dissections involve the descending

aorta (similar to DeBakey type III).
cardiac emergency
49
o History

Time of onset.
Symptoms.
location of pain especially in the (chest, back, or abdomen),
Character of pain.
Radiation of pain.
Alleviating or aggravating factors.
Other associated symptoms.
Past medical history.
History of long-standing hypertension.
Previous cardiac surgery.
Previous aortic pathology.
Medications.
Information about allergies to intravenous iodinated contrast.
Family history.
Social history.
50
cardiac emergency
Hypertensive (49%), normotensive (35%), hypotensive

(8%), or in shock (8%).
Pulse deficit.
The pulmonary examination.
Cardiac examination: new murmurs, distant heart sounds,

jugular venous distension, and tachycardia.
Neurological findings.
Mesenteric ischemia.
Syncope.

Aortic Regurgitation.
Aortic Stenosis.
Cardiac Tamponade.
Cardiogenic Shock.
Cardiomyopathy.
cardiac emergency
51
Cerebrovascular Accident.
Gastrointestinal Bleed.
Hemorrhagic Shock.
Hypovolemic Shock.
Hiatal Hernia.
Hypertensive Urgency.
Mediastinitis.
Myocardial Infarction.
Myocarditis.
Pancreatitis.
Pericarditis.
Pleural Effusion.
Pneumonia.
Pulmonary Embolism.
Thoracic Outlet Syndrome.
52
cardiac emergency
o Work up

Ultrasound.
CT.
MRI.
Conventional Aortography/Angiography.
CBC.
Electrolytes.
BLLOD GROUPING & CROSS MATCHING.
Cardiac enzymes.
LFTS.
Pancreatic enzymes.
Urinalysis.
ECG.
cardiac emergency
53
Management
o Prehospital Care:

Rapidly transporting them to the appropriate facility.
Transported via advanced life support.
Intravenous access.
Cardiac monitor.
Supplemental oxygen.
Intravenous fluids should be given if the patient is hypotensive.
Close monitoring of vital signs.
In hospital care:

A target heart rate of < 60 beats/min and a systolic blood

pressure between 100 and 120 mm Hg are recommended to
prevent progression of dissection.
Intravenous narcotics titrated to pain control.
Intravenous beta-blockers administered first.

Options include propranolol, metoprolol, labetalol, or esmolol.
54
cardiac emergency
Esmolol has the advantage of a very short halflife, while labetalol is an alpha- and beta-receptor
antagonist and may be more effective in controlling both heart rate and blood pressure as a single
agent.
Patients with contraindications to beta-blockers

(eg, severe asthma, chronic obstructive pulmonary
disease, acute congestive heart failure, or cocaine
toxicity) should be given intravenous calciumchannel blockers such as verapamil or diltiazem.
In cocaine toxicity, intravenous benzodiazepines

should be given to decrease the sympathetic drive.
To further reduce blood pressure, intravenous vasodilator ( not used alone ).
cardiac emergency
55
Medication
Dosage
Comments
Beta blockers (recommended as first-line treatment; target

heart rate < 60 beats/min
Esmolol
Beta 1-receptor
blocker
Labetalol
Alpha 1-, beta 1-,
and beta 2-receptor
blocker
Metoprolol
Beta 1-receptor
blocker
Bolus 500 mcg/kg

IV, then infusion
at 50-200 mcg/
kg/min
Preferable due
to short half-life
and easy titration; may be preferred inasthma/
COPD
10-20 mg IV push
q10min up to 300
mg maximum;
infusion 0.5-2.0
mg/min
May be used as a
single agent
5 mg IV q5min up No IV infusion
to 15 mg maxi- available
mum
Propranolol
1 mg IV q5 min No IV infusion
up to 0.15 mg/kg available
Beta 1-, beta 2-recep- maximum
tor blocker
Calcium-channel blockers (target heart rate < 60 beats/min)
56
cardiac emergency
Diltiazem
Bolus 0.2-0.25
mg/kg IV, then
infusion 5-15 mg/
.hr
Second-line
for heart rate
control when
beta blockers are
contraindicated
(e.g., cocaine
toxicity, COPD,
or asthma exacerbation)
Verapamil
5-10 mg IV
NA
Vasodilators (give beta blocker first to prevent reflex tachycardia; target SBP 100-120 mm Hg)
Nitroglycerin
Start 10-20 mcg/

min infusion.
Titrate 5-10 mcg/
min q10min to a
maximum of 100
mcg/min
Not a first-line
vasodilator
cardiac emergency
57
Disposition
Admission to the intensive care unit.
Close monitoring.
Strict blood pressure and heart rate control.
Type A aortic dissections will usually require transfer to a

center with cardiac surgery capabilities.
Type B aortic dissections may be cared for by either a cardiothoracic surgeon or a vascular surgeon, depending on the
institution.
Coordination of care with the treating surgeon will determine

whether or not surgical repair is indicated.
58
cardiac emergency
Deep Venous Thrombosis

Overview
Venous thrombosis is a condition in which a blood clot

(thrombus) forms in a vein. This clot can limit blood flow
through the vein, causing swelling and pain.
Most commonly, venous thrombosis occurs in the deep
veins in the legs, thighs, or pelvis this is called a deep vein
thrombosis, or DVT.
o History

When did the pain start? The time line of pain onset is
important; pain that has been present for weeks without
change is unlikely to be acute DVT. This may lead to
suspicion for other conditions, such as ongoing arterial
insufficiency.
Did the pain begin with any event, such as localized

trauma or a strain?
Did the pain come on suddenly, or more slowly?
Were there any associated occurrences with the onset

cardiac emergency
59
of pain, such as a pop that may be associated with a

muscle, tendon, or cyst rupture?

Is there any swelling in the leg and, if so, where?
Is there any redness, or does the skin feel hot?
Has this ever happened before?
Have you been immobilized recently, either due to injury/surgery, or for other reasons, such as a lengthy automobile trip?
Past Medical History:

Malignancy or a history suggestive of malignancy.
Recent hospitalization, pregnancy (including
current pregnancy, recent pregnancy (within
2 months), and recent abortions or miscarriages) and the puerperium, use of hormonal
agents, or known acquired or inherited thrombophilia.
Obesity and smoking.
60
cardiac emergency

Signs of immobility (e.g., presence of a

cast).
Tenderness and its location.
Swelling or pain upon squeezing the calf.
Palpation of a painful area, especially the

calf, reveals a thickened, thrombosed vein.

Cellulitis.
Bakers Cyst.
Superficial thrombophlebitis.
cardiac emergency
61
Work up

CBC.
Electrolytes.
PT/PTT and INR.
Venography.
Duplex ultrasound.
D-Dimer.
Management
o Prehospital Care:

Primarily supportive.
If the patient is asymptomatic, then no need for intravenous access.
Start heparin if transportation time is prolonged and patient was moderate to high risk.
In hospital care:
62
cardiac emergency
Unfractionated heparin using a loading dose of 80

units/kg, then 18 units/kg/h.
The heparin dose is subsequently adjusted based on

PTT measurement after 6 hours of infusion, usually
once the patient has been admitted to the hospital.
Low molecular weight heparin as:

-
Enoxaparin one mg /kg SC every 12

hours.
Delteparin 100IU/kg SC every 12

hours.
OR
200IU/kg SC every day.
Tinzaaparin 175 IU/kg SC every day.
Disposition
Admit most patients with DVT for intravenous unfractionated heparin.
Patients who are sent home after a negative duplex ultrasound should have a repeat
ultrasound examination in 5 to 7 days.
cardiac emergency
63
64
Patients who are low-risk, have a negative duplex ultrasound, and a negative (reliable) D-dimer do not require
any further ultrasound examination, unless the concern
for DVT otherwise increases (e.g., worsening symptoms).
cardiac emergency
Chapter
2
PULMONARY
EMERGENCY
cardiac emergency
65
Acute Bronchial Asthma in the Emergency

Department
Overview
o Risk Factors for Death from Asthma:
66
Previous severe exacerbation (ie, intubation, ICU admission).
Two or more hospitalizations for asthma in the past

year.
Three or more ED visits for asthma in the past year.
Hospitalization or ED visit for asthma in the past

month.
Using > 2 canisters of a short-acting beta agonist per

month.
Difficulty perceiving asthma symptoms or severity of

exacerbations.
Social History.
Low socioeconomic status or inner-city residence.
Illicit drug use.

Pulmonary Emergency
Major psychosocial problems.
Comorbidities.
Cardiovascular disease.
Concomitant lung disease.
Chronic psychiatric disease.
Abbreviations: ED, emergency department; ICU, intensive care
unit.
o History

Past history of sudden severe exacerbations
Prior intubation for asthma
Prior asthma admission to an intensive care unit
Two or more hospitalizations for asthma in the past

year
Three or more emergency department care visits for

asthma in the past year
Pulmonary Emergency
67
Hospitalization or an emergency department care visit

for asthma within the past month
Use of >2 MDI short-acting 2-agonist

canisters per month
Current use of or recent withdrawal from

systemic corticosteroids
Difficulty perceiving severity of airflow

obstruction
Comorbidities such as cardiovascular diseases or other systemic problems
Serious psychiatric disease or psychosocial

problems
Illicit drug use, especially inhaled cocaine

and heroin
68
Alterations in mentation or consciousness.
Diaphoresis.
Tachypnea and tachycardia
Use of accessory muscles of respiration.
Pulmonary Emergency
Wheezing.
Identify the complications of asthma such as

pneumonia, pneumothorax, or pneumomediastinum.
Adults
Chronic obstructive pulmonary disease
Acute coronary syndromes
Congestive heart failure
Pulmonary embolism
Pneumothorax
Pneumonia
Airway foreign body
Gastroesophageal reflux disease
Vocal cord dysfunction
Cystic fibrosis
Chronic bronchitis
Pulmonary Emergency
69
Sinus disease
Upper respiratory tract infection.
Children
Croup
Viral and bacterial pneumonia
Airway foreign body
Bronchiolitis
Tracheomalacia
Viral upper respiratory tract infection
Work up
70
Complete blood count (if patient is for

admission).
Electrolyte evaluation (if patient has dehydration or for admission)..
Arterial blood gas (if patient is not responding to initial treatment).
Chest radiography (if there is no response to

treatment or pneumonia).
Pulmonary Emergency
Management
o Prehospital Care:
Oxygenation monitoring with pulse oximetry,

Hemodynamic monitoring with noninvasive blood

pressure.
Inhaled short acting beta agonists by nebulizer or metered-dose inhaler with spacer.
In hospital care:
Mild-Moderate
Severe
FEV1 or PEFR%
>50%
Unable or
<50%
Oxygen
Maintain SaO2 >90%
Maintain
SaO2 >90%
Nebulized solution
5 mg q2030 min 3
doses
Salbutamol (ventoline)
MDI with spacer:
Racemic albuterol
(90 mg/puff)
612 puffs q20 min for up

to 4 hr. (with supervision)
Same but
may be
unable to do
(with supervision)
Pulmonary Emergency
71
Inhaled anticholinergic:
Nebulized
ipratropium solution
0.5 mg q2030 min 3

doses (mix with albuterol
solution)
Systemic
corticosteroids
Oral (preferred):
4060 mg prednisone or
equivalent
IV (unable to take PO or
absorb):
60125 mg methylprednisolone (or equivalent)
IV magnesium
sulfate (FEV1
<25%)
Not indicated
4060 mg
prednisone
or equivalent
60125 mg
methylprednisolone (or
equivalent)
23 g over
20 min
FEV1, forced expiratory volume in 1 second; MDI,

metered-dose inhaler; PEFR, peak expiratory flow rate;
SaO2, oxygen saturation in arterial blood.
72
Pulmonary Emergency
Disposition
Good Response
FEV1 or
PEFR%
(predicted/
personal
best)
>70%
Incomplete
Response
>50% but <70%
Poor Response
<50%
Disposition site:
Home
Yes
No, continue
therapy
No,
continue
therapy
Observation
unit
No
Yes, if available
Yes, if
available
and appropriate
Hospital
ward
No
Yes, if no observation unit.
Yes, if appropriate
Critical care
unit
No
No
Yes, if with
respiratory
insufficiency/failure
FEV1, forced expiratory volume in 1 second; PEFR,
peak expiratory flow rate.
Pulmonary Emergency
73
Alert

Still have significant symptoms.
Concerns about compliance (with treatment regime).
Living alone or socially isolated.
Psychological problems.
Physical disability or learning difficulties.
Previous near fatal or brittle asthma.
Exacerbation despite adequate dose steroid tablets pre-presentation (current steroid use).
Presentation at night.
Pregnancy.
Normal PCO2 is a worsening sign.
74
Pulmonary Emergency
Chapter
3
NEUROLOGICAL
EMERGENCY
cardiac emergency
75
Acute Headache
Overview
o Tension-Type Headache
1. At least 10 episodes of headache attacks lasting from 30 minutes to 7 days
2. At least two of the following criteria:
Pressing/tightening (nonpulsatile) quality
Mild or moderate intensity (may inhibit but does not prohibit
activity)
Bilateral location
No aggravation by walking, stairs, or similar routine physical
activity
3. Both of the following:
No nausea or vomiting (anorexia may occur)
Photophobia and phonophobia are absent, or one but not both
are present.
76
NEUROLOGICAL EMERGENCY
Migraine without Aura
1. At least five headache attacks lasting 4 to 72 hours (untreated or

unsuccessfully treated), which have at least 2 of the 4 following
characteristics:
Unilateral location.
Pulsating quality.
Moderate or severe intensity (inhibits or prohibits daily activities).
Aggravated by walking, stairs, or similar routine physical activity.
1. During headache, at least one of the two following symptoms
occur:
Phonophobia and photophobia.
Nausea and/or vomiting.
Cluster Headache
1. At least 5 attacks of severe unilateral orbital, supraorbital, and/
or temporal pain lasting 15 to 180 minutes untreated, with One
or more of the following signs occurring on the same side as
the pain:
77
Conjunctival injection
Lacrimation
Nasal congestion
Rhinorrhea
Forehead and facial sweating
Miosis
Ptosis
Eyelid edema
1.
Frequency of attacks is from one every other day to 8

per day.
Other Primary Headaches

Includes:
Primary exertional headache
Hypnic headache.
Primary thunderclap headache.
Primary headache associated with sexual activity.
78
o History
Detailed account of the current headache.

Special attention to red flag symptoms that may

suggest a dangerous secondary etiology:
New headache in-patient older than 50 years of age.

Maximal intensity within minutes of onset (thunderclap headache).
Posterior headache with neck pain or stiffness.
Change in vision.
Change in consciousness.
Syncope.
History of HIV or immunocompromised.
History of malignancy.
Pregnancy or postpartum.
History of neurosurgery or cerebral shunt
Headache with seizure.
79
The onset.
Location.
Quality of the headache as well as associated symptoms.
Explore differences between the current headache and prior

headaches.
As such, the descriptive worst headache must be taken in

the context of other signs and symptoms.
Important Secondary Causes of Headache:

Secondary Headache
Causes
Red-Flag Findings
Subarachnoid hemor
rhage
Thunderclap (sudden, severe

onset) headache
Meningitis
Fever, neck stiffness, immunosuppression
Temporal arteritis
Jaw claudication, vision changes,

polymyalgia rheumatica
Carbon monoxide
poisoning
Waxing and waning headache,

cluster of cases
Acute glaucoma
Unilateral vision change, eye pain,

and redness
80
Cervical artery dissec

tion
Neck pain, trauma, stroke symptoms, Horner syndrome
Venous sinus throm

bosis
Pregnancy, postpartum, hypercoagulable, oral contraceptive use
Intracerebral tumor
Chronic progressive headaches,

papilledema, history of malignancy
Cerebellar infarction
Ataxia, dysmetria, vertigo, vomiting
Idiopathic intracranial
Papilledema, worse when lying

flat, obesity
hypertension
Pituitary apoplexy
Hypotension, hypoglycemia,
hyponatremia, visual field deficit,
history of pituitary tumor
Pre-eclampsia
Hypertension, proteinuria, nondependent edema, pregnancy
Hypertensive encepha
lopathy
Altered mental status, hypertensive, neurologic signs in nonanatomic distribution
Subdural hematoma
Trauma, coagulopathy
Intracerebral hemor
rhage
Hypertension, cerebral aneurysm,

arteriovenous malformation
81

Neurologic Examination.
Ophthalmologic Examination.
Head and Neck Examination.
Cardiopulmonary and abdominal examinations.
General History Questions For Evaluation Of Headache

History Questions
Onset:
When did the headache

start?
What were you doing
when it started?
Concerning Responses
Sudden headache with exercise, coughing, straining,

or orgasm is concerning
for SAH.
Provocation:
What makes the pain
better or worse? Position?
Exercise? Straining?
Pain exacerbated by supine

position or cough is concerning for increased ICP.
Quality:
Occipital headache with

neurologic signs of
dysarthria, dysphagia,
double vision, or ataxia are
concerning for posterior
bleed, tumor, or stroke.
Describe the pain.

Where is the pain
located?
82
Radiation:
Does the pain move or
radiate?
Severity:
How long until your
headache reached its
maximum?
Temporal:
Has the pain changed
over time
Associated:
Are there any other

symptoms you have had?
Pain with radiation down

the neck or neck stiffness
is concerning for SAH,
meningitis, or carotid or
vertebral artery dissection.
Thunderclap headache
(maximal pain within minutes of onset) is concerning
for secondary pathology
including SAH, venous
sinus thrombosis, or intracranial hemorrhage.
Chronic, progressively
worsening headaches are
concerning for possible
structural mass or lesion.
Associated neurologic
deficits, vision changes,
or fever are concerning
for dangerous secondary
etiology.
Abbreviations: ICP, intracranial pressure; SAH, subarachnoid

hemorrhage
83
Selected Concerning Neurologic Examination Findings

For The Headache Patient
CranialNerve/Examination Finding:
Possible Cause:
CN II Optic nerve or its

central connections
Unilateral vision loss can

be the result of ischemia,
temporal arteritis, glaucoma,
or optic neuritis.
Vision loss / visual field

deficit
CN III Oculomotor nerve

Defect in pupillary
constriction, eyelid raise,
extraocular movements
(down and out eye)
CN VI Abducens nerve
Defect in lateral movement
of eye
84
Bilateral visual field loss

suggests CNS involvement
posterior to the optic chiasm.
May indicate posterior
communicating artery aneurysm, uncal herniation, SAH,
or mass lesion.
Consider cavernous sinus
thrombosis.
Consider increased or
decreased ICP, brain herniation.
Ataxia, coordination deficit

Unsteady gait, unable to
perform finger-to-nose, heelto-shin
Altered mental status
Consider cerebellar infarct

or bleed.
Consider posterior/vertebral
injur
Concern for mass or vascular
lesion, SAH, hypertensive
encephalopathy, meningitis,
venous sinus thrombosis,
carbon monoxide poisoning,
or dissection.
Abbreviations: CN, cranial

nerve; CNS, central nervous
system; ICP, intracranial
pressure; SAH, subarachnoid
hemorrhage.

Trauma, SAH, CNS tumor/mass.
Cerebral/dural venous thrombosis, pituitary

apoplexy, hypertensive encephalopathy.
Meningitis, SAH, idiopathic intracranial hypertension.
Acute glaucoma.
85
Temporal arteritis.
Carbon monoxide.
o Work up

Noncontrast head computed tomography (CT).
(MRI).
Magnetic resonance venography (MRV) BRAIN.
Lumbar puncture with cerebrospinal fluid analysis.
Visual acuity and intraocular pressure.
ESR.
Carboxyhemoglobin.
86
Excluding Secondary Causes Of Headache, By Study

Test
Secondary Cause
Noncontrast CT
head
Trauma, SAH, CNS
MRI/MRV brain
tumor/mass
Cerebral/dural venous thrombosis, pituitary apoplexy,
hypertensive encephalopathy
Lumbar
puncture
with Meningitis, SAH, idiopathic
cerebrospinal fluid analysis intracranial hypertension
and OP (opening pressure)
Visual acuity with IOP
Acute glaucoma
Erythrocyte sedimentation
rate
Temporal arteritis
Carboxyhemoglobin
Carbon monoxide
Abbreviations: CNS, central nervous system; CT, computed

tomography; IOP, intraocular pressure; MRI, magnetic resonance imaging; MRV, magnetic resonance venography; OP,
.opening pressure; SAH, subarachnoid hemorrhage
87
Management
o Prehospital Care:
Generalized recommendations include the following:
1. Eliciting a basic history.
2. Evaluating mental status.
3. Performing a brief neurologic examination.
NB: If there is any abnormality in the neurologic or mental status
examination or if the patient appears unwell, emergent transport
.should be activated
In the field, the initial approach includes:

Making the patient comfortable prior to giving

medications.
Adjusting temperature.
Minimizing unnecessary light or noise.
Placement into a comfortable position.
Acetaminophen can be used as a first-line medication.
88
In hospital care:

Secondary headaches must be excluded first.
Primary headache:
NSAIDs - first-line therapy for migraine headaches:
For mild pain:

Ibuprofen 400-600 mg PO.
CONSIDER Sumatriptan 100 mg PO or 6 mg SQ.
For severe pain:

Diphenhydramine 25 mg IV
And

Prochlorperazine 10 mg IV.
Or

Metoclopramide 20 mg IV.
Consider

Dexamethasone 10 mg IV.
89
IV Fluid.
Triptan.
Consider expert consultation.
Contraindications for Triptan Use:

Uncontrolled hypertension.
Ischemic heart disease.
Prinzmetal angina.
Cardiac arrhythmias.
Multiple risk factors for atherosclerotic vascular disease.
Primary vasculopathies.
Basilar and hemiplegic migraine.
Use of ergot in past 24 hours.
Use of MAOI or SSRI.
Use of triptan in past 24 hours.
90
Management of Cluster Headache

Acute abortive therapy for cluster headaches falls into two groups:
1.
Oxygen; 6-10 L facemask.
2.
And Sumatriptan 6 mg SQ.
91
Medications For Primary Headache, Dosing, And American

.Academy Of Neurology Quality Of Evidence
Medication
Dose
AAN Quality
of Evidence
Ibuprofen
mg PO 400-600
Aspirin
mg PO 1000
Naproxen
mg PO 500-825
Ketorolac
mg IV 15-30
Acetaminophen
mg PO 900-1000
Aspirin / acetaminophen / caffeine
mg / 500 mg / 130 500

mg PO
Dihydroergotamine
IV
mg IV 0.5-1
Chlorpromazine
mg/kg IV 0.1
B/C
Metoclopramide
mg IV 20
Prochlorperazine
mg IV 10
Sumatriptan SQ
mg SQ 6
Sumatriptan PO
mg PO 100
Opioids
Varies
Dexamethasone
mg PO/IV 6-10
Abbreviations: AAN, American Academy of Neurology; IV,

.intravenous; PO, by mouth; SQ, subcutaneous
92
Disposition

To set return precautions.
Patients should be given return precautions for red-flag signs.

Alerts of Dangerous Secondary Headaches:
New headache in-patient older than 50 years of age.
Maximal intensity within minutes of onset (thunderclap headache).
Posterior headache with neck pain or stiffness.
Change in vision.
Change in consciousness.
Syncope.
History of HIV or immunocompromised.
History of malignancy.
Pregnancy or postpartum.
History of neurosurgery or cerebral shunt
Headache with seizure.

Follow-up with a primary doctor.
93
Adult Acute Bacterial Meningitis

Overview
Risk Factors for Meningitis:
94
Age greater than 50 years.
Upper respiratory tract infection.
Otitis media.
Sinusitis.
Mastoiditis.
Head trauma.
Recent neurosurgery.
Compromised immune system (eg, resulting from human immu nodeficiency virus [HIV], diabetes mellitus,
asplenia, alcoholism, cirrhosis/liver disease, malnutrition, malignancy, cirrhosis/liver disease, malnutrition,
malignancy, and immunosuppressive drug therapy).
Crowded living conditions.

Headache And Nausea
Fever
Altered Mental Status
Neck Stiffness/Nuchal Rigidity
Kernig And Brudzinski Signs
Other Signs/Symptoms

Tripod position with the knees and hips flexed, the back
arched at a lordotic angle, the neck extended, and the
arms brought back to support the thorax.
Focal neurologic deficits.
Rash.
Arthritis.

Encephalitis.
Aseptic meningitis.
Intracranial abscess.
Metabolic encephalopathy.
95
Work up

Complete Blood Cell Count, Chemistry Panel, Lactate

Level, and Blood Cultures, coagulation profile.
Computed Tomography.
Lumbar Puncture.
Management
o Prehospital Care:
Standard personal protective
equipment such as facial masks.
96
Vital signs and mental status during transport.
Administer supplementary oxygen.
Blood glucose check.
Glasgow Coma Scale (GCS)

score.
Two large-bore IVs with normal

saline infused.
Pain medication.
In hospital care:

Dexamethasone.
Empirical antimicrobial:
Predisposing Factor
Common Bacterial
Pathogen
Antimicrobial
Therapy
Age 16-50
years
Neisseria meningitidis,
Streptococcus pneumoniae, Haemophilus influenzae (nonimmunized
)patients
Vancomycin plus
a third-generation
cephalosporin
Age > 50
years
Streptococcus pneumoniae, Neisseria meningitidis,

Listeria monocytogenes,
aerobic gram-negative
bacilli
Vancomycin plus
a third-generation
cephalosporin and
ampicillin
Immunocompromised
System
Listeria monocytogenes,
aerobic gram-negative
bacilli, Streptococcus
pneumoniae, Neisseria
meningitidis
Vancomycin plus
a third-generation
cephalosporin and
ampicillin
Cerebrospinal Trauma
Staphylococci, aerobic
gram-negative bacilli,
Streptococcus pneumoniae
Vancomycin plus
either a third-generation cephalosporin with anti-pseudomonal coverage
or meropenem
97
Disposition

98
Admission to hospital.
Chapter
4
TOXICOLOGY
cardiac emergency
99
Acetaminophen (Paracetamole,APAP) Overdose

Toxicity in adults is likely to occur after a single ingestion of
greater than 150 mg/kg or 10 g over a 24-hour period.
Progression of Liver Disease after Acute APAP Ingestion:

Stage/Approx- Description
imate Duration
Stage 1
0-24 hours
Preclinical injury
phase
Results of
Laboratory
Tests
Manifestations
Normal
Asymptomatic or mild,
nonspecific
symptoms:
AST in severe poisoning
nausea,
vomiting,
anorexia,
malaise
Stage 2
24-72 hours
100
Onset of
liver injury
TOXICOLOGY
ALT, h AST,
bilirubin,
PT,
lactate,
phosphate,
creatinine
Nausea, vomiting, RUQ

pain
Stage 3
72-96 hours
Maximal
hepatotoxicity
Stage 4
5-7 days
Recovery
phase
LFTs, ATN,
creatinine,
ammonia
Normalization
Jaundice,
coagulation
defects, hypoglycemia,
renal failure,
encephalopathy, coma,
MSOF
Complete
resolution of
hepatotoxicity
o History
Dose and time of APAP ingestion.

Formulation of APAP ingested the pattern of use (single

dose or repeated doses).
Duration of ingestion.
Concomitant ingestions.
Intent of use (e.g., suicidal gesture or for analgesia).
History of trauma.
TOXICOLOGY
101
Coexisting illnesses.
Witnesses and/or family members.
History of liver injury or alcoholism.
102
ABCs
The heart should be monitored for dysrhythmias.
Tachycardia may suggest congestion of a sympathomimetic or anticholinergic agent.
Dehydration.
Blood loss.
Pain.
Agitation.
Tachypnea may indicate metabolic acidosis, respiratory

alkalosis, or hypoxia.
Abdomen to detect RUQ pain and hepatic enlargement,
Mental status which could suggest encephalopathy.
Pupils
TOXICOLOGY
Skin
Evidence of depression, suicide attempts,

psychiatric illnesses.

Ascending cholangitis.
Biliary disease.
Hepatorenal syndrome.
Hypercalcemia.
Ischemic hepatitis (shock liver).
Fulminant viral hepatitis(hepatitis A, B, B/D, or

E;Epstein-Barr, cytomegalovirus)
Pancreatitis.
Perforated viscus.
Reyes syndrome.
Toxin-induced hepatic failure:
Mushroom toxicity (amatoxin).

Other toxins.
TOXICOLOGY
103
o Work up
104
Obtain blood paracetamol level at 4 hours after ingestion.
In patients who have a toxic APAP level, follow-up serum testing 12 to 24 hours after the first results.
A serum APAP concentration drawn between 4 and 24

hours after an isolated ingestion should be plotted on
the Rumack-Matthew Nomogram.
CBC
LFTS
Serum lipase concentration.
URIN ANALYSIS
Toxicology Panel And Rumack-Matthew Nomogram
Coagulation Studies
Chemistry Panel And Other Blood Work
Pregnancy Test
Electrocardiography
Head Computed Tomography

TOXICOLOGY
Management
o Prehospital Care
Amount of APAP ingested and any congestion.

Evidence of trauma.
Vital signs, monitoring cardiac and pulse oximetry, and

administering supplemental oxygen.
Plasma glucose concentration.
Obtunded patients should be intubated.
A suspected suicide attempt or intentional poisoning by

a third party, the patient should be brought to the ED
for evaluation and treatment regardless of the amount
ingested.
In hospital care

Activated charcoal (up to one hours after ingestion).
Administer antidotal therapy (N-acetylcysteine):
The loading dose is 140 mg/kg, followed every 4 hours

by additional doses of 70 mg/kg, to total of 17 doses.

Treat fulminant hepatic failure.

TOXICOLOGY
105
Refer patient for urgent liver transplant if criteria

are met.
Provide supportive and appropriate follow-up

care:
l Control nausea and vomiting

l Manage renal dysfunction
Admission
l
Monitor and treat hypoglycemia
l Vitamin K and fresh frozen plasma for coagulopathy.
Disposition
106
If the level is not toxic with normal AST level patient

is at minimal risk for toxicity, and treatment with NAC
is not indicated, can be given medical clearance and a
psychiatric evaluation. At discharge, patients should be
instructed to return immediately if symptoms of hepatic
injury arise (e.g., abdominal pain, vomiting).
Hepatotoxicity, renal dysfunction, or multisystem organ

involvement, admission to the intensive care unit (ICU).
TOXICOLOGY
Carbon Monoxide Poisoning

Overview

At room temperature, CO is a gas that is odorless, tasteless, and not irritating.
Carbon monoxide impairs oxygen delivery and peripheral utilization, causing cellular hypoxia.
Carbon monoxide binds to hemoglobin with an affinity

more than 200 times that of oxygen after rapidly diffusing across the pulmonary capillary membrane, forming
Carboxyhemoglobin (COHb) resulting in leftward shift
of the normal oxyhemoglobin dissociation curve, which
reduces tissue oxygen delivery.
o History
Questions to ask include:
Where was the patient found, and under what circumstances?
Was there clear evidence of CO exposure?
Was there loss of consciousness?
TOXICOLOGY
107
Was there evidence of trauma?

Was a finger stick glucose determination performed?
Was noninvasive co-oximetry performed?
Was prehospital ECG performed?
Was there evidence of attempted self-harm or suicidal intent?
Trauma, neurologic, and cardiovascular examinations.
Oropharynx for edema and soot.
Neck should be carefully examined for the presence of stridor.
Cardiac wheezing or crackles in the lungs, signifying myocardial depression secondary to smoke inhalation.
108
Acuterespiratory distresssyndrome.
Alcohol toxicity.
Altitude illness.
Cluster headache.
TOXICOLOGY
Cyanide poisoning.
Depression.
Diabetic ketoacidosis.
Encephalitis.
Gastroenteritis.
Hypoglycaemia.
Hypothyroidism.
Labyrinthitis.
Lactic acidosis.
Meningitis.
Methaemoglobinaemia.
Migraine.
Smoke inhalation.
Tension headache.
Alcohol toxicity.
Narcotic toxicity.
TOXICOLOGY
109
o Work up

Co-oximetry.
Carboxyhemoglobin Testing (in ABG).
Cardiac Biomarkers.
Lactate.
Pregnancy Testing.
Toxicological Testing (if there is coingestion).
Chest x-ray.
Computed Tomography.
ECG.
Management
o Prehospital Care:

110
Recognize the potential for CO poisoning and examination of the scene for evidence of combustion or abnormal odors or fumes.
TOXICOLOGY
An intravenous (IV) catheter.
Empiric treatment with oxygen during transport is

recommended.
o In hospital care:
Signs of end-organ dysfunction and COHb level significantly elevated:
Treat with normobaric oxygen (NBO)- (100% O2).

Discuss hyperbaric oxygen (HBO) treatment with HBO chamber staff.
Disposition
Patients who did not have loss of consciousness.
Complete recovery from any symptoms.
COHb level has returned to normal.
No evidence of end-organ damage (ECG changes, elevated

cardiac biomarkers, neurological deficits) may be safely discharged to home.
TOXICOLOGY
111
Patients with end-organ toxicity will require

hospitalization, with or without HBO therapy.
o Alert
112
Severe headaches.
Dizziness.
Mental Confusion.
Nausea.
Fainting.
Pregnancy.
TOXICOLOGY
Chapter
5
HEMATOLOGICAL
EMERGENCY
cardiac emergency
113
Sickle cell disease in emergency department

Overview
Sickle cell disease (SCD) is genetically mutated hemoglobin

(HbS) forms rigid polymers when deoxygenated; giving red
blood cells a characteristic sickled shape. Increased blood
viscosity and cell adhesion produce intermittent vaso-occlusion.
The vaso-occlusive phenotype of SCD, which is marked by

higher hemoglobin, manifests with frequent painful crises
and is associated with a higher risk for developing acute
chest syndrome.
The hemolytic phenotype is characterized by lower baseline

levels of hemoglobin and elevated markers of hemolysis.
o History
-Pain:
-What complications of SCD have you had?
-Pain - Acute chest syndrome Stroke - Infections - Avascular
necrosis - Priapism Cholecystitis - Splenic sequestration - Renal failure - Pulmonary hypertension - Pulmonary disease - Leg
ulcers - Vision loss
114
Hematological Emergency
-What surgeries have you had?

Cholecystectomy - Splenectomy - Joint replacement Tonsillectomy
-How often do you have pain?
-How often do you come to the ED for pain?
-Have you ever been on chronic transfusions?
-What medicines do you take for pain at home?
-What is your baseline hemoglobin level?
MedicationsPhysical Examination

Eyes.
Mucous membranes for jaundice.
Auscultate for cardiac murmurs.
Focal pulmonary abnormalities.
Abdomen: both liver & spleen.
Each pain location.

115
Signs of infection (tenderness, erythema,

fluctuance).
Common
Rare
Extremely Rare
Vaso-occlusive
crisis
Acute coronary syndrome
Hepatic sequestration
Infection
Splenic sequestration
Renal infarction
Stroke
Osteomyelitis
Cholelithiasis
Transient red cell

aplasia
Splenic infarction
Priapism
Retinal detachment
Mesenteric
ischemia
o Work up
116
CBC.
L.F.T.
Reticulocyte count.
ALT.
LDH.
Bilirubin fractionation (direct or indirect).
Blood typing and screening.
o Management
o Prehospital Care

Oxygen in respiratory distress.
IV fluid boluses to hypotensive patients.
Administer IV opioids in pain and venous access

is obtained.
Transport patients who are already being followed by a specific hematology service to that hospital.
o In hospital care

Start D5 normal saline at the maintenance rate.
117
Opiate therapy:
Administer IV dose of opiate:
Morphine 0.1-0.15 mg/kg.
Non opiate Therapy:

Antihistamines
Acetaminophen
Non-Steroidal Anti-Inflammatory Drugs
Assess degree of relief every 15-30 minutes

o Disposition
Admission to hospital if:
118
Uncontrolled pain.
Blood transfusion needed.
Infections.
Complication of Vasso- Occlusive Crisis.
Anticoagulation Emergencies
Overview
Target INRs for the anticoagulated Patient:
Indication
Target INR (range)
Deep vein thrombosis, pulmonary

embolus.
2.5 (2.0-3.0)
Atrial fibrillation
2.5 (2.0-3.0)
Mechanical heart valve
3.0 (2.5-3.5)
Mitral valve stenosis
2.5 (2.0-3.0)
Cardiomyopathy
2.5 (2.0-3.0)
Ischemic cerebrovascular disease.
2.5 (2.0-3.0)
119
Drugs That Potentiate Warfarin:

Drug
Effect
Sulfonamides21
Strongest effect of all antibiotics;

inhibits CYP2C9 (hepatic microsomal
metabolism)
Fluoroquinolones21,25-27
Including levofloxin, initially thought

not to interact. Inhibits CYP2C9
and decreases vitamin K-producing
bacteria
Doxycycline
Inhibits warfarin metabolism
Amoxicillin
Inhibits warfarin metabolism
Antifungals25
Inhibit CYP2C9
Acetaminophen25
Interferes with vitamin K cycle
Metronidazole
Inhibits warfarin metabolism. Decreases vitamin K-producing bacteria
Amiodarone
Inhibits CYP2C9
o History

Reasons why the patient is anticoagulated.
Last INR levels & last checked.
120
Degree of anticoagulation.
History of medications.

Level of consciousness using the Glasgow Coma Scale

(GCS).
Pupillary response.
Motor examination.
Sensory examination.
Flank, back, or abdominal tenderness, the diagnosis of

retroperitoneal hemorrhage must be considered.
Clinical Signs Of Retroperitoneal Hemorrhage
Sign:
Location of ecchymosis:
Celluens
Periumbelical
Tumers
Flanks
Foxs
Upper thigh, inferior to inguinal ligament
Bryants
Scrotum
121

Intracerebral/ intracranial hemorrhage.
Spinal epidural hematoma.
Retroperitoneal hemorrhage.
Rectus sheath hematoma.
Hemothorax.
Gastrointestinal bleeding.
Hemopericardium.
Compartment syndrome.
Hematuria.
o Work up

CBC
Chemistry Panel.
Coagulation profile.
Type and Screen/Crossmatch.
Urinalysis.
122
o Imaging
According to presentation and possible complications.

Head Computed Tomography.
Abdominal Computed Tomography.
Magnetic Resonance Imaging.
o Management
o Prehospital Care:

All Anticoagulated patients with head injury should be transported to a facility with 24-hour diagnostic imaging, and
there should be a low threshold for transporting to a trauma
center with neurosurgical capabilities.
Direct pressure at the bleeding site is recommended.
Universal precautions including gloves, mask, and eye protection or face shield.
Hand-washing after touching blood, body fluids, and contaminated items
Tourniquets are not routinely indicated to control bleeding.
123
o In hospital care:
o Management of Supratherapeutic INR:
If serious or life- threatening administer all of the following:
Vitamin K 10 mg IV slowly (Can be repeated every 12 hours).
FFP.
PCC or rFVIIa*.
o If no bleeding:
INR = 3 to < 5
1. Omit next dose
2. Recheck INR frequently.
INR = 5 to < 9
1. Omit next 1 or 2 doses
2. Recheck INR
3. Consider oral vitamin K (1- 2.5 mg) if at increased risk of
bleeding,
124
INR = 9
1. Omit next 1 or 2 doses
2. Administer oral vitamin K (2.55 mg)
3. Recheck INR within 24-48 hours.
* If PCC or rFVIIa is unavailable, proceed with vitamin K and
FFP.
Abbreviations: FFP, fresh frozen plasma; INR, international normalized ratio; PCC, prothrombin complex concentrate; rFVIIa,
recombinant activated factor VII.
Management of Minor Head Injury in the Anticoagulated Patient:
If INR is not elevated:
Standard head injury management.
If elevated INR and head CT shows intracranial hemorrhage:

If serious or life- threatening administer all of the following:
Vitamin K 10 mg slow IV.
FFP.
PCC or rFVIIa*.
125
If elevated INR and head CT shows no intracranial hemorrhage:
Observe 6-12 hours, depending on hospital protocol.

Repeat CT scan.
Correct INR
o Disposition

Most asymptomatic patients can be discharged

home unless they have little support or they are a
significant fall risk.
significant complications of anticoagulation will

result in admission.
126
Chapter
6
ENDOCRINOLOGY AND
ELECTROLYTE EMERGRNCY
cardiac emergency
127
Hypokalemic and Hyperkalemia Emergencies
Overview
Hypokalemia, defined as a serum potassium level < 3.5

mEq/L.
Hypokalemia is divided into the following 3 categories:
Mild: K+ 3.0-3.5 mEq/L.

Moderate: K+ 2.5-3.0 mEq/L.
Severe: K+ < 2.5 mEq/L.

The causes of hypokalemia fall into 3 basic categories:

(1) Inadequate potassium intake.
(2) Excessive loss of potassium.
(3) Transcellular shift of potassium.
128 Endocrinology and electrolyte Emergency
Hyperkalemia, defined as serum potassium level 5.5

mEq/L.
Hyperkalemia can be divided into the following 3

categories:
Mild: K+ 5.5-6.5 mEq/L
Moderate: K+ > 6.5-7.5 mEq/L
Severe: K+ > 7.5 mEq/L

The causes of hyperkalemia fall into 3 basic categories:

(1) Laboratory error and factitious hyperkalemia.
(2) Transcellular shifting of potassium.
(3) Potassium excretion insufficiency.
(4) increase K+ intake
Endocrinology and electrolyte Emergency
129
o History
Generalized weakness.

Flaccid paralysis.
Loss of deep tendon reflexes.
Respiratory difficulty.
Gastrointestinal complaints.
Kidney disease.
Endocrine disease.
New medications started in the last year including diuretics, ARBs, ACEIs, diabetes medications, or thyroid
medications.
Recent trauma.
Recent gastrointestinal illnesses.
Recent surgery or hospitalizations.
Recent changes in fluid intake or losses.
History of familial periodic paralysis.
Organ
System
Cardiac
Hypokalemia

Hyperkalemia
Dysrhythmias
C o n d u c t i o n
defects
Increased likelihood of dysrhythmias due
to digitalis
Dysrhythmias
Conduction
bances
Weakness
Paresthesia
Paralysis
Hyperreflexia
Cramping
Skeletal
muscle
Weakness
Paralysis
Fasciculations
and tetany
Gastrointestinal
Ileus

Nausea

Vomiting

Abdominal
distention
Renal
Polyuria
distur-
Nausea
Vomiting
Diarrhea
131
Diabetes.
Myocardial infarction.
Stroke.
Viral illnesses.
Myasthenia gravis.
Botulism.
Spinal cord diseases.
Polyneuropathies.
Cataplexy.
o Work up

ECG.
Complete blood count (CBC) with platelets.
Metabolic and renal panel.
Urine studies.
Arterial blood gas, serum and urine osmolality, and urine electrolytes.
o Electrocardiogram in Hypokalemia

Flattened T-waves.
ST-segment depression.
U-waves.
o Electrocardiogram in Hyperkalemia

Peaked T-wave.
Flattened P-wave.
Prolonged PR interval.
Absent P-wave.
Wide QRS.
Sine-wave pattern.
133
Management
o Prehospital Care:

In hypokalemia, treating symptoms of the underlying

cause.
In hyperkalemic-induced dysrhythmias and cardiac

arrest, advanced Cardiac Life Support (ACLS)
guidelines are followed.
In hospital care:
Management of Hypokalemia

mild hypokalemia (3.0-3.5 mEq/L):

Asymptomatic and the treatment of their underlying disorder.
Potassium chloride PO 20-80 mEq/d in divided doses.
Discharge with recommendation to increase
dietary K+
moderate to severe hypokalemia (< 3.0 mEq/L):

symptomatic or has life-threaten-
ing ECG changes:

Potassium chloride IV 20 mmol/
hr (Max rate: 20 mmol over 10
min followed by 10 mmol over 10
min).
Magnesium sulfate IV 5 mL 50%
(10 mmol [2 g]) over 30 min.

Recheck K+ after every 40 mmol if normal

renal function or after every 20 mmol (if
severe renal impairment).
Management of Hyperkalemia

Mild to moderate hyperkalemia (6.5-7.5

mEq/L).
o Patient clinically stable.

o Regular insulin 10 units IV plus 50
mL of D50.
Life-threatening hyperkalemia Any of the

following:
135
o Peaked T-waves (amplitude > R in

2 leads).
o Absent P-waves.
o Broad QRS.
o Sine wave.
o Bradycardia.
o Ventricular tachycardia.
o K+ level more than 7.
Start:
Calcium chloride IV 10 mL 10% (6.8 mmol) over 5 min.
Regular insulin 10 units IV plus 50 mL of D50.
Salbutamol 10-15 mg, nebulized.

Cardiac arrest (VT, VF, PEA, asystole):
Commence ACLS
Consider hemodialysis.
Disposition
Hypokalemic patients:
Tolerant of potassium by mouth and whose symptoms have

resolved can be discharged with a short course of potassium
as long as they have close follow-up.
If the patient remains symptomatic or does not tolerate potassium by mouth, admission is advised.
Hyperkalemic patients:
Potassium levels > 8.0 mEq/L, patients with acute worsening

of renal function, and those with comorbid medical conditions should be admitted.
Potassium levels 6.5 mEq/L should be treated and ad-
mitted in a monitored bed for close observation and treatment.
Potassium level of 5.5-6.5 mEq/L, the disposition will

vary depending on the underlying cause.
137
Diabetic Emergencies
Overview
Diabetic Ketoacidosis
Hyperglycemic Hyperosmolar
Syndrome
Ketoacidosis
Profound
Minimal or none
Glucose
~250-600 mg/
dL
Often >900 mg/dL
< 15 mEq/L
> 15 mEq/L
300-325
mOsm
Often > 350 mOsm
Young
Elderly
Acute; over
hours to days
Chronic; over days to weeks
Associated
diseases
Common
Common
Seizures
Very rare
Common
HCO3
Osmolarity
Age
Onset
Coma
Rare
Common
Insulin
levels
Very low to
none
May be normal
Mortality
0%-10%
20%-40%
(depends on
underlying
conditions)
Dehydration
Severe
Profound
History

Polyuria.
Polydipsia.
Polyphagia.
Weight loss.
Fatigue and weakness.
Abdominal pain.
Nausea and vomiting.
Hyperventilation.
139
Is there an associated infection?

Is there another associated illness?
What other medications has the patient been taking?

The mucous membranes dry.
Skin turgor decreased.
Sunken eyes.
Tachycardia and hypotension.
The pulse may be weak and thready.
Abdominal pain or tenderness, nausea and

vomiting.
Lack of bowel sounds, and ileus.
Compensatory hyperventilation from the

metabolic acidosis (Kussmaul respiration).
Febrile.
Fruity breath in DKA.
Work up

CBC.
Full Chemistry.
VBGS.
Serum Glucose.
Serum Ketones.
Serum Osmolality.
Urinalysis and Urine Culture.
Lumbar Puncture (if clinically indicated).
Hemoglobin A1C Determination.
Management
Prehospital Care:

Primarily supportive.
Providers should have access to blood glucose measurement devices.
141
Intravenous line should be started and normal saline given as a bolus of up to 1 liter in
the average-sized adult.
Medications should be identified and brought

to the ED.
Identification of precipitating or comorbid

illnesses.
High incidence of infection in HHS patients

has led to a recommendation for early empiric antibiotic therapy, even if no source is
identified.
Diabetic Ketoacidosis
Fluids:

Hypotensive, administer a bolus of 1-2 liters

of normal saline (0.9%) over the first hour
(pediatric dose, 20-40 mL/kg).
If hypotension persists, then give another

bolus.
If the patient is normotensive, then use 0.9%

saline at 1000 cc per hour.
The patient has renal failure or has a history

of congestive heart failure, and then invasive
monitoring with central venous pressure
(CVP) monitor.
Insulin:

Intravenous insulin administration regimen is

continuous infusion of 0.1 units per kilogram
per hour (after you have K+ level).
Bicarbonate:

The use of bicarbonate is not recommended

for DKA.
Potassium:
-K > 5.5 mEq/L
Hold K.
Check K every 2 hours.
-K 3.3-5.5 mEq/L
Give 20-30 mEq to keep serum potassium at about 4-5 mEq/L.
143
-K < 3.3 mEq/L

Hold insulin.
Give K (40 mEq in adults) per hour until K > 3.3 mEq/L.
Careful Monitoring:

Glucoseevery 1-2 hours by fingers tick

(confirmed by laboratory correlation when
indicated).
Basic metabolic profile for anion gap and

serum potassiumat the onset of treatment,
at one and two hours after the onset of treatment, and at two- to four hour intervals until
the patient is substantially better.
Arterial or venous pHsfollow as indicated

to monitor clinical status.
Insulin dose and route of administration

every hour.
IV fluidsevery hour.
Urine outputevery hour.
Disposition
Admit the patient to the ICU if:

hemodynamic instability;
unable to defend the airway (this patient

should be promptly intubated);
obtunded (this patient should also be

promptly intubated);
abdominal distention, acute abdominal signs,

or symptoms suggestive of acute gastric
dilatation are present (surgical consultation
should be considered for these patients);
Insulin infusions cannot be administered on

the ward.
monitoring cannot be provided on the ward;
Co-morbid disease such as sepsis.
Myocardial infarction or trauma.
145
Overview
Thyrotoxicosis refers to any state characterized by a clinical
excess of thyroid hormone. Thyroid storm represents the extreme
.presentation of thyrotoxicosis
Myxedema coma is used to describe the severe life-threatening
.manifestations of hypothyroidism
The term myxedema coma itself is a misnomer, as patients do
not usually present with frank coma but more commonly have altered mental status or mental slowing. Myxedema actually refers
to the nonpitting puffy appearance of the skin and soft tissues
.related to hypothyroidism
147
o History
Historical Questions In The Evaluation Of Thyroid Storm
History of thyroid disease?

Symptoms of hyperthyroidism: tremor, agitation, weight
loss, nervousness, heat intolerance, proximal weakness, palpitations, menstrual irregularity?
Thyroid manipulation?
Medication changes?
Physiologic stressors: trauma, infections, exertion?
Recent anesthesia?
Recent iodinated contrast?
Infectious syndromes?
Historical Questions In The Evaluation Of Myxedema Coma
History of thyroid disease?

Symptoms of hypothyroidism: weight gain, hair loss, fatigue,
weight gain, dry skin, voice change, depression, constipation,
Menstrual irregularity?
Medication changes often with menometrorrhagia.
Physiologic/psychological stressors: infection, trauma, cold
exposure, major life changes?
The patient with thyrotoxicosis classically presents:

Febrile.
Tachycardia (widened pulse pressure).
Tremulous.
149
Weakness.
Weight loss.
Palpitations.
The patient with hypothyroidism classically presents:

Blood pressure low to elevate.
Skin changes.
Hypothermia.
Pseudomyotonic deep tendon reflexes.
Depressed mental function.
Nonpitting edema.
Weight gain.
Differential Diagnosis in Thyroid Storm

Hypoglycemia.
Hypoxia.
Sepsis.
Encephalitis/meningitis.
Hypertensive encephalopathy.
Alcohol withdrawal.
Benzodiazepine/barbiturate withdrawal.
Opioid withdrawal.
Heat stroke.
Differential Diagnosis in Myxedema Coma

Hypoglycemia
Hypoxia
Sepsis
Hypothermia due to environmental exposure
Cerebrovascular accident
Acute myocardial infarction
Intracranial hemorrhage
Panhypopituitarism
151
Adrenal insufficiency
Hyponatremia
Gastrointestinal bleeding
Conversion disorder
o Work up

TSH, T4 and T3.
Full chemistry.
Cardiac markers.
B-type natriuretic peptide level.
Serum lactate levels.
Random cortisol level.
Urinalysis.
Urine pregnancy test or b-hCG.
An arterial blood gas.
Electrocardiogram.
Chest Radiography.
Echocardiography.
Computerized Tomography Head.
Lumbar Puncture (if indicated).
Management
o Prehospital Care:

Support of airway, breathing.
Vital Signs.
Circulation with emergent transport to the

ED.
Blood glucose levels.
Rewarming for hypothermic patients.
Warm humidified oxygen.
Chemical and physical restraints.
Cardiac monitor and have continuous pulse

oximetry.
153
In hospital care:
o Management of myxedema coma:

Intravenous replacement of thyroxin.
T4 is administered in a dosage of 200 to 500

g IV.
(Pediatric dosage 10 mcg/kg/d IV divided q6-8).

Empiric glucocorticoids.
Hydrocortisone at 100 mg IV (pediatric dosage 0.5-1

mg/kg IV q8) is the recommended dose.
Thyroid Storm:
Three-Step Treatment Of Thyroid Storm
Goal
Treatment
Effect
Step 1
Block
peripheral
effect of
thyroid hormone
Provide continuous intravenous

infusion of
-blocking agent
Slows heart
rate, increases
diastolic filling,
and decreases
tremor.
Step 2
Stop the
production of
thyroid hormone
Provide antithyroid medication

(propylthiouracyl
or methimazole)
and dexamethasone.
Antithyroid
decrease synthesis of thyroid
hormone in the
thyroid.
Propylthiouracyl
slows conversion of T4 to T3
in periphery.
Dexamethasone
decreases conversion of T4 to
T3 in periphery.
Step 3
Inhibit hormone release
Give iodide 1-2 h

after antithyroid
medication
Decreases release of thyroid

hormone from
thyroid.
155
Disposition
Admission must be in ICU department.
Chapter
7
UROLOGICAL
EMERGECY
cardiac emergency
157
Rhabdomyolysis: Advances in Diagnosis and

Treatment
Overview
Rhabdomyolysis is a potentially life-threatening condition characterized by the breakdown of skeletal muscle and the release of
intracellular contents into the circulatory system.
o History
Localizing myalgia.

Muscle stiffness.
Cramping, swelling.
Tea-colored urine.
158
Extremity swelling.
Tenderness.
Motor weakness.
Sensory deficits.
Pain with passive range of motion.
UROLOGICAL EMERGRNCY
Coma (from any cause), prolonged general anesthesia.
Seizures, alcohol withdrawal syndrome, strenuous exercise, tetanus, severe dystonia, acute mania.
Thromboembolism, external compression, carbon

monoxide poisoning, sickle cell disease.
Heat stroke, malignant hyperthermia, neuroleptic malignant syndrome, serotonin syndrome, hypothermia/
frostbite.
Lightning strike, high-voltage injury, electrical cardioversion.
Hypokalemia (licorice ingestion, diarrhea, diuretics,

primary hypoaldosteronism) hypophosphatemia, hyponatremia, hypernatremia.
Ethanol, methanol, ethylene glycol, heroin, methadone, barbiturates, cocaine, caffeine, amphetamine,
LSD, MDMA (ecstasy), mushrooms, PCP, benzodiazepines, toluene, etc.
Crush syndrome, compartment syndrome
Antihistamines, salicylates, neuroleptics (neurolepUROLOGICAL EMERGRNCY
159
tic malignant syndrome), cyclic antidepressants and

selective-serotonin reuptake inhibitors (via serotonin
syndrome), anticholinergics, laxatives (likely via electrolyte abnormalities), anesthetics and paralytic agents
(especially succinylcholine), quinine, corticosteroids,
theophylline, aminocaproic acid, propofol, colchicine,
antiretrovirals, etc.
160
Bacteria: Escherichia coli, Shigella, Salmonella,

Streptococcus pneumoniae, Staphylococcus aureus,
Group A Streptococcus, Clostridium, etc.
Viruses: Influenza A and B, cytomegalovirus, herpes

simplex virus, Epstein-Barr virus, HIV, coxsackievirus, West Nile virus, varicella-zoster virus.
Inherited disorders manifest with enzyme deficiencies

in carbohydrate and lipid metabolism or myopathies.
Polymyositis, dermatomyositis, Sjgren syndrome.
Systemic lupus erythematosus.
Hypothyroidism, thyroid storm.
Snakebite, bee envenomation, scorpion sting, spider

bite.
Cardiac arrest, cardiopulmonary resuscitation.
o Work up

Serum creatine phosphokinase (CK) levels.
Urine Dipstick and Urinalysis.
Complete blood count (CBC).
Electrolyte evaluation.
Liver function tests.
Electrocardiogram (ECG).
Management
o Prehospital Care:

Rapid recognition.
Consideration of the diagnosis in the trauma patient

with victims of building collapse or direct extremity
trauma with significant swelling.
Immediate IV fluid resuscitation to prevent renal failure.
161
o In hospital care:
CK < 1000

Repeat CK in 8 hours
CK > 1000, but < 5000

Start 0.9% saline 400 mL/hr.
Recheck CK periodically
CK > 5000

Start 0.9% saline 400 mL/hr.
Monitor hourly urine output.
Goal: 200 mL/hr.
Disposition
.Admission in all cases
162
Acute Urinary Retention

Overview
Gender-Specific Causes of Acute Urinary Retention:
Women
Obstructive Causes
Men
Obstructive Causes
Cystocele
BPH
Tumor
Meatal stenosis
Phimosis/ paraphimosis
Infectious Causes
Operative Causes
Tumor
Infectious Causes
Operative causes
Abbreviation: BPH, benign prostatic hypertrophy.

History
The location, movement, and radiation of the pain.
Medications.
163
Chemical exposure.

History of psychiatric illness.
Suicidal intent or ideation.
Weight loss, bone pain.
Urinary frequency, urgency, hesitancy, nocturia, difficulty

initiating a urinary stream, decreased force of stream, incomplete voiding, or terminal dribbling.
Dysuria, urgency, discharge, chills, fever, low back pain,
and genital itching.
Rectal examination should be performed to rule out rectal
or uterine prolapse.
Enlarged prostate.
Phimosis or paraphimosis, lesions, and tumors.
Uterine prolapse, cystocele, enlarged uterus, or enlarged
ovaries.
Neurological examination, focusing on strength, sensation, and lower extremity reflexes.
164

Benign prostatic hypertrophy.
Bladder calculi.
Bladder clots.
Meatal stenosis.
Neoplasm of the bladder.
Neurogenic etiologies.
Paraphimosis.
Penile trauma.
Phimosis.
Prostate cancer.
Prostatic trauma/ avulsion.
Prostatitis.
Urethral foreign body.
Urethral inflammation.
Urethral strictures.
165
o Work up

CBC.
Prostate-specific antigen (PSA) levels.
Electrolytes, blood urea nitrogen, and creatinine levels.
Urinalysis and culture.
Renal ultrasound.
Computed tomography [CT] scan.
Magnetic resonance imaging (MRI).
Management
o Prehospital Care
166
Alleviating pain.
Correcting hypovolemia.
Foley catheter placement.
In hospital care
Complete decompression of the bladder through urinary

catheterization with a double-lumen Foley catheter.
The current American Urological Association guidelines

only recommend using the 5-alpha reductase inhibitors (finasteride and dutasteride) in men with considerable prostate
enlargement on digital rectal examination.
Treatment of underlying cause.
Disposition

Concomitant infection, significant comorbid illnesses, impaired renal function, neurological deficits, or complications
of catheterization require emergent urological consultation
and admission.
With BPH, the catheter should be left in place at discharge

from the ED and Follow up with a urologist within 3 days.
167
168
Chapter
8
TRAUMA AND
ENVIRONMENTAL
cardiac emergency
169
Severe Traumatic Brain Injury

Overview
o Classification:
Primary injury: Induced by mechanical force and occurs at the moment of injury; the 2 main mechanisms
that cause primary injury are contact (eg, an object
striking the head or the brain striking the inside of the
skull) and acceleration-deceleration.
Secondary injury: Not mechanically induced; it may be

delayed from the moment of impact, and it may superimpose injury on a brain already affected by a mechanical injury.
Initial GCS
Mild head
injury
Moderate head
injury
Severe head
injury
14-15
9-13
3-8
% of total
80
10
10
Mortality (%)
<1
10-15
30-50
Good functional
outcome (%)
>90
20-90
<20
170
Trauma and Environmental
The most commonly used method for grading the severity of brain
injury is the Glasgow Coma Score (GCS).
Glasgow Coma Score
Eye Opening
(E)
Verbal Response (V)
Motor Response
(M)
4=opens
5=normal conversation 6=normal
spontaneously 4=disoriented
5=localizes pain
3=opens to
voice
4=withdraws from
pain
2=opens to
pain
1=none
conversation
3=words, incoherent
2=incomprehensible
3=decorticate posturing
sounds
2=decerebrate
1=none
posturing
1=none
o History
AMPLE history:
171
A- Allergies.
M- Medications.
P- past medical history.
L- Last meal.
E- events/environment related to the injury.
Information from EMS, family members, or

bystanders can be very valuable.
Mechanism of injury.
Speed involved and potential severity of trauma.
Loss of consciousness - how long it lasted?
Nausea.
Vomiting.
Visual difficulty.
172

Evidence of scalp trauma, skull fractures, or signs of basilar

skull fracture (characteristic ecchymosis, or CSF otorrhea or
rhinorrhea).
Neurological examination.
GCS.
Pupillary examination.

Acute Stroke.
Cerebral Aneurysms.
Epileptic and Epileptiform Encephalopathies.
Hydrocephalus.
Metastatic Disease to the Brain.
Prion-Related Diseases.
Psychiatric Disorders Associated With Epilepsy.
Subarachnoid Hemorrhage.
Subdural Empyema.
173
Subdural Hematoma.
Temporal Lobe Epilepsy.
Tonic-Clonic Seizures.
o Work up

Blood Glucose Level.
Evaluation of blood alcohol level.
Urine or blood drug screen.
CBC.
Chemistry profile.
Coagulation profile.
ABG.
Blood typing in case future transfusions.
Non-contrast CT scan.
174
Management
o Prehospital Care

Bystander and emergency medical system (EMS) activation.
Make an appropriate decision about whether the patient

should be transported by air or by ground.
A-B-C-D assessment.
Degree of disability.
GCS.
Assessment and treatment of other traumatic injuries
Full spinal immobilization.
Oxygen saturation.
Blood glucose.
Supplemental oxygen
Airways secured with an airway adjunct.
Intubation with GCS less than 8
175
In hospital care:

Airway.
Breathing.
Fluid Resuscitation.
Intracranial Pressure Monitoring.
Medical Therapy for Increased ICP: mannitol 0.25 mg - 1.0
mg/kg.
Anticonvulsants: phenytoin or fosphenytoin (20 mg/kg or 20
phenytoin equivalents/kg respectively.
Disposition

Hospital admission: preferably to a trauma ICU or to a neurosciences ICU.
Early consultation with neurosurgery and trauma surgery
ED without trauma support should be transferred to a tertiary

hospital with neurosurgery and trauma surgery capabilities
as soon as the patient is stable for transport and after consultation with both of these services.
176
Alert
Loss of consciousness at any time.
GCS <15 on initial assessment.
Focal neurological deficit.
Retrograde or anterograde amnesia.
Persistent headache.
Vomiting or seizures post injury.
177
Electrical Injuries
Overview
Comparison of High-Voltage and Low-Voltage Electrical Injuries:
Characteristic
Low-Voltage
Injury
High-Voltage
Injury
Voltage, V
1000 V
> 1000 V
Type of Current
Alternating current
Alternating current
Duration of
Contact
Prolonged
Brief (if direct current)
Cause of Cardiac
Ventricular fibrillation
Asystole
Arrest
Cause of Respira- Thoracic muscle

tory
tetany
Arrest
Muscle contraction
Tetanic
or direct current
Thoracic muscle
tetany or indirect
trauma
Tetanic (if alternating
current); single
(if direct current)
178
Burns
Superficial
Deep
Rhabdomyolysis
Less common
More common
Blunt injury
Does not usually
Caused by falls and

violent muscle contractions
Occur
o History

Bystanders and Prehospital providers are a good resource regarding the electrical source, the voltage, the
duration of contact, environmental factors at the scene,
and resuscitative measures already provided.
Special attention should be paid to the electrical source.
injury that initially appears to have resulted from a lowvoltage source (e.g., a household appliance) may be due
to a high-voltage source
Medical history (especially cardiac problems), medications, allergies, and tetanus immunization status should
also be obtained.
179
180
The size and location of any burns and the condition of

the patients extremities noted.
Small, well-demarcated entry and exit wounds are often

seen with low-voltage electrical injuries
Depressed, necrotic-appearing burns are more commonly observed in high-voltage injuries.
Assessment of vision and hearing should include fundoscopic and otoscopic examination.
look for tympanic membrane rupture,
The full range of motion of all joints should be tested to

assess for fractures and dislocations
Serial neurovascular checks on all extremities are also

necessary
Practice Guidelines For Cardiac

Monitoring After Electrical Injuries
Characteristic
Cardiac monitoring
NOT required if
ALL IS
the following are true
Cardiac monitoring
is required if ANY
the following are true
of the
Electrocardiogram
Normal
Documented
arrhythmia or
evidence of ischemia
History of
loss of consciousness
No
Yes
Type of injury
Low-voltage ( 1000
)volts
High-voltage (> 1000

)volts
181
182
Chemical burn.
Ocular burn.
Thermal burn.
Intracranial hemorrhage.
Lightning Injuries.
Respiratory arrest.
Rhabdomyolysis.
Seizures.
Status Epilepticus.
Syncope.
Ventricular Fibrillation.
o Work up

Electrocardiogram.
CBC.
FULL CHEMISTRY.
CK levels.
Creatine kinase myocardial isoenzyme (CK-MB).
Head computed tomography (CT).
183
Laboratory Tests Recommended

For Patients With Electrical Injuries
Test
Rationale/Indication
CBC
All patients with injuries beyond

minor cutaneous burns
Electrolytes

BUN and creatinine

Urinalysis
To evaluate for myoglobinuria

(positive for blood but no red
blood cells)
Serum myoglobin
If urinalysis is positive for myoglobinuria
Liver function tests/ I

amylase/lipase
If intra-abdominal injury is
suspected
Coagulation profile
If intra-abdominal injury is
suspected or if surgical course is
projected
Blood type and screen/

Crossmatch
If surgical course is projected
184
Management
o Prehospital Care

Secure the scene.
Turn off the power source.
Involve the local electric company.
Use (ACLS) protocols.
Patients cervical spine is immobilized with a cervical

collar and backboard, any fractures are splinted, and
burns are covered with clean, dry dressings.
Large-bore intravenous line.
Normal saline or Lactated Ringers Solution should be

given to any patients with cutaneous burns or hypotension.
Transport to the closest appropriate facility
185
Cutaneous Injuries

Cleaned and then covered with sterile dressings.
Antibiotic dressings, such as mafenide acetate or sulfadiazine silver should be used to cover the wounds.
Mafenide acetate is preferred for localized full-thickness burns because it has better penetration.
Sulfadiazine silver is preferred for extensive burns because it is less likely to cause electrolyte abnormalities.
Tetanus immunization.
Management of Injury to the Extremities
186
When electrothermal burns affect an upper extremity,

the limb should be splinted with the wrist at 35 to 45
of extension, the metacarpophalangealjoint at 80 to
90 of flexion, and nearly full extension of the proximal
and distal interphalangeal joints (Z position) to minimize the space available for edema formation.
The extremity should be kept elevated above the level

of the heart to reduce edema.
Frequent neurovascular checks of all extremities
Treatment of compartment syndrome.
Myoglobinuria
Fluid resuscitation should be directed at maintaining a

urine output of 1.0 to 1.5 cc/kg per hour until the urine
is clear of myoglobin.
Acute myoglobinuric renal failure with life-threatening

consequences.
Disposition

Patients with injuries due to electrical burns, including

lightning injury, should be referred to a burn center.
ICU admition.
All patients with a history of loss of consciousness, documented arrhythmias either before or after arrival to the
ED (including cardiac arrest), ECG evidence of ischemia, or who have a sustained a high-voltage electrical
injury should be admitted for additional monitoring.
187
Heat Injuries
Overview
The most serious type of heat related illness is heat stroke.
Heat stroke definition includes:
(1) A core body temperature of more than 105F (40.5C).
(2) Central nervous system dysfunction.
(3) Exposure to heat stress, endogenous or exogenous, and
(4) Exclusions to include CNS infection, sepsis, neuroleptic malignant syndrome or malignant hyperthermia secondary to anesthetic agents.
188
Risk factors for Development of Heat Stroke by Type:

Classic
Both
Exertional
Elderly
Drugs
Children
Obesity
Protective clothing
Current febrile
illness
Recent alcohol
consumption
Prior dehydrating illness
Lack of sleep,
food or water
Social isolation
Confined to bed
Debilitated
Lack of air conditioning
Live on top floor of
a building
Heat Wave
Skin diseases
(i.e. anhydrosis, psoriasis)
Metabolic
conditions
increasing
Chronic mental
illness
heat production
(i.e. thyrotoxicosis)
Cardiopulmonary
disease
Lack of acclimatization
Chronic illness
Prior heat
stroke
Lack of physical
fitness
Lighter skin
pigmentation
Motivation to
push
oneself/warrior
mentality
Reluctance to
report
problems
Previous days
heat exposure
Elevated Heat
Index
Lack of coach or
athlete education
regarding heat
illness.
189
o History

Information must be sought from EMS personnel, witnesses, and family members.
Medications.
Preceding events in order to understand the circumstances of the heat injury, e.g., medical illness or
exertional activities.
190
ABCs and reviewing the initial vital signs.
Tachycardia.
Hypotension.
Tachypnea and tachycardia.
Mental status.
Hydration status.
Delirium Tremens.
Diabetic Ketoacidosis.
Encephalopathy, Hepatic.
Encephalopathy, Uremic.
Hyperthyroidism.
Meningitis.
Neuroleptic Malignant Syndrome.
Tetanus.
Toxicity, Cocaine.
Toxicity, Phencyclidine.
Toxicity, Salicylate.
o Work up

CBC
Serum Chemistries
191
Chest radiograph
Computed tomography (CT) of the Head
Echocardiography.
o Diagnosis of Heat Stroke:

A core body temperature of generally more than 105F

(40.5C) though may be slightly lower.
Central nervous system dysfunction.
Exposure to heat stress, endogenous or exogenous.
Exclusions to include CNS infection, sepsis, neuroleptic

malignant syndrome or malignant hyperthermia secondary
to anesthetic agents.
Some sources include a marked elevation of hepatic transaminases, however this is not universal.
192
Management
o Prehospital Care

Patient should be placed in a shaded area.
Tepid water may be applied to the patient in order to

initiate the evaporation process
Manual fanning.
The patient should be removed from any external heat

sources if applicable.
EMS transport should be initiated with the appropriate

level of transport capability.
Gradual rehydration with exertional heat stroke.
Clothing removal, external cooling through fanning or

air-conditioning, and continuous monitoring are all appropriate prehospital measures that can be undertaken.
193
In hospital care:
o Heat stroke:
194
Rapidly removing clothing.
Pouring tepid water over the body.
Directing a fan on the patient.
Icepacks in both axillae and the groin (not used alone,

but as a combination with evaporative cooling).
Aggressive cooling with goal < 38.3 C in 30-60 min:

if goal is reached:
Start diagnostic studies.
If goal is not reached:
Consider invasive cooling methods:

Gastric, pleural and bladder lavage.
Intravascular cooling device.
Extracorporeal circuits.
Disposition

Admit all heat stroke victims to ICU.
195
196
cardiac emergency
Chapter
9
MEDICATIONS LIST
cardiac emergency
197
Antiplatelet drugs:
Code
Item
Dosage
form
Stength
545021160
Acetyl Salicylic Acid
Tablet
75 mg
100 mg
Tablet
75 mg
(Aspirin); (Enteric
Coated)
543021233
Clopidogrel (Plavix)
Nitrates, Calcium-Channel blacker and Peripheral

vasodilators:
Code
Item
Dosage form
Stength
544021055
Nitroglycerin
Sublingual Tablet
0.4-0.6 mg
544021051
Nitroglycerin
Ampule- vial
50 mg
Opioid Analgesic:
Code
Item
Dosage form
Stength
545024051
Morphine
Sulfate
Ampule
10 mg
Fibrinolytic drugs:
198
MEDICATIONS LIST
Code
Item
Dosage form
Stength
543063182
Alteplase
Vial
50 mg
543063183
Reteplase
Set
10 mg
543044250
Streptokinase
Vial
250,000 I.U
543044260
750,000 I.U
Anticoagulants:
Code
Item
Dosage form
Stength
543024210
Heparin
Calcium
Ampoule
5000 I.U
543024201
Heparin
Sodium
Vial
25000I.U/5ml
543024214
Enoxaparin
Prefilled
syringe
8000 I.U
543024208
Dalteparin
Prefilled
syringe
10000 I.U
MEDICATIONS LIST
199
Atrial Fibrillation: Management Strategies

Antiarrhythmic drugs:
Supraventricular and Ventricular arrhythmias:
Code
Item
Dosage
form
Stength
544061410
Amiodarone HCL
Tablet
200 mg
544064415
Amiodarone HCL
Ampoule
150 mg
Diltiazem
Vial
25mg/5ml
544031110
Diltiazem HCL
Tablet
60 mg
544031112
Diltiazem HCL
SR
Tablet
90 mg
Bradydysrhythmias
Code
Item
Dosage form
Stength
545064890
Atropine
Sulfate
Ampule
0.4-0.6
mg/1ml
545064892
Atropine
Sulfate
Prefilled syringe
0.1mg/ml
544094610
Dopamine
HCL
Ampoule or Vial
200 mg
544094612
Dopamine
HCL
Premixed bag
800 mg IN
250ml
D5Wmbag
200
MEDICATIONS LIST
544094621
Adrenaline
(Epinephrine)
Prefilled Syringe
1:10000
(100mcg/ml)
10 ml
544094640
Isoprenaline
HCL (Isoproterenol
HCL)
Ampoule
200 mcg/ml
(5 ml)
Specific Antidotes and Therapies for Toxicological Causes of

Bradydysrhythmias
Code
Item
Dosage form
Stength
547064650
Glucagon
Vial
1 mg
547064655
Glucagon
Prefilled
syringe
1 mg
548024310
Calcium Gluconate
Ampoule
10%
(10ml)
547064580
Human Soluble
Insulin (Regular)
Vial
100I.U/ml
(10ml)
551054365
Digoxin immune
fab
Ampoule
40 mg
551074480
Naloxone
Ampoule
40mcg/2ml
551074470
Naloxone
Ampoule
400 mcg/
ml
545064890
Atropine Sulfate
Ampule
0.4-0.6
mg/1ml
MEDICATIONS LIST
201
545064892
Atropine Sulfate
Prefilled
syringe
0.1mg/ml
551054380
Pralidoxim chloride
Vial
1gm
Hypertension
Code
Item
Dosage
form
Strength
544104770
Sodium nitroprusside
Ampoule or
Vial
50 mg
Nicardipine
hydrochloride
Vial
25mg/10 mL
Fenoldopam
mesylate
Vial
10m/ml
544021051
Nitroglycerin
Ampoule or
Vial
50 mg
Enalaprilat
Vail
1.25 mg / ml
544104730
Hydralazine
hydrochloride
Ampoule
20 mg
544104770
Sodium nitroprusside
Ampoule or
Vial
50 mg
Nicardipine
hydrochloride
Vial
25 mg / 10 ml
202
MEDICATIONS LIST
Fenoldopam
mesylate
Vial
20 mg / 2 ml
544101790
Labetalol hydrochloride
Ampole or
Vial
5mg/ml
100mg/20ml
544054214
Esmolol hydrochloride
Ampoule or
Vial
100 mg
544104750
Phentolamine
Ampoule or
Vial
10 mg
544071450
Hydrochlorothiazide
Tablet
25 mg
544101747
Lisinopril
10 mg
544101746
Enalapril
10 mg
544101740
Captopril
25 mg
544101745
Perindopril
544101738
Fosinopril
10 mg
544101749
Losartan
50 mg
544101750
Valsartan
80 mg
544101757
Irbesartan
544101760
Telmisartan
Tablets
4-5 mg
150 mg
Tablet
80 mg
MEDICATIONS LIST
203
544051207
Metoprolol
50 mg
544051201
Propranolol
10 mg
544051205
Propranolol
544051173
Atenolol
40 mg
Tablet
50 mg
544051171
Atenolol
100 mg
544101795
Labetolol
100 mg
544051172
Carvidolol
6.25 mg
544051206
Bisoprolol
2.5 mg
544051180
Carvidolol
25 mg
544051203
Bisoprolol
5 mg
544051208
Metoprolol
50 mg
544051253
Satolol HCL
80 mg
544031110
Diltiazem
60 mg
544031112
Diltiazem
)(SR
90 mg
Tablet
544031105
544031120
544031125
544031126
Nimodipine
Verapamil
30 mg
Tablet
40 mg
80 mg
Verapamil
120 mg
Verapamil
544101703
Clonidine
Tablet
100 mcg
544101725
Hydralazine
Tablet
25 mg
204
MEDICATIONS LIST
Acute aortic emergency

Code
Item
Dosage form
Strength
544054214
Esmolol
Ampoule or
Vial
100 mg
544051208
Metoprolol
Ampoule
5 mg
544101790
Labetalol
Ampoule or
Vial
5 mg/ml
(100mg/20mg)
544021051
Propranolol
Ampoule or
Vial
50 mg
Diltiazem
Vail
1.25 mg / ml
544034130
Verapamil
Ampoule
5 mg
544024051
Nitroglycerin
Ampoule or
Vial
50 mg
Deep Venous Thrombosis

Code
Item
Dosage form
Strength
543024210
Heparin Calcium
Ampoule
5000 I.U
543024201
Heparin Sodium
Vial
25000 I.U /
5 ml
543024221
Tinzaparin
Vial
20000 IU
543024219
Tinzaparin
Prefilled
syringe
18000 IU
543024220
Tinzaparin
Prefilled
syringe
14000 IU
MEDICATIONS LIST
205
543024218
Tinzaparin
Prefilled
syringe
10000 IU
543024214
Enoxaparin
Prefilled
syringe
8000 IU
543024204
Deltaparin
Prefilled
syringe
IU 7500
543024217
Tinzaparin
Prefilled
syringe
4500 IU
Enoxaparin
6000 IU
543024216
Enoxaparin
Prefilled
syringe
6000 IU
543024207
Deltaparin
Prefilled
syringe
5000 IU
543024212
Enoxaparin
Prefilled
syringe
2000 IU
543024213
Tinzaparin
Prefilled
syringe
3500 IU
543024211
Deltaparin
Prefilled
syringe
2500 IU
206
MEDICATIONS LIST
Acute Bronchial Asthma in the Emergency Department

Code
Item
Dosage form
Strength
549012030
Albuterol
Nebulization Solution
0.5 % 20 ml /
bottle
549016040
Albuterol
Metered Inhaler
dose inhalations
25000 I.U /
5 ml
549016110
Ipratropium
Nebulization Solution (Unite dose

ampoule )
20000 IU
547051420
Prednisolone
Tablet
5 mg
547051430
547054450
20-25 mg
Methylpredniso547054460
lone
Ampoule Or vial
548024460
Ampoule or vial
IV magnesium
sulfate
40 mg
500 mg
10% (20 ml)
MEDICATIONS LIST
207
Acute Headache
Code
Item
Dosage form
Strength
545021200
Ibuprofen
Tablet
400 mg
545024323
Sumatriptan
Tablet
50 mg100 mg
545031556
Diphenhydramine
HCL
Vial
25 mg
546054420
Metoclopramide
Ampoule
10 mg
547054480
Dexamethasone
Ampoule
8
mg/2ml
545021160
Aspirin
Tablet
75-100
mg
545021252
Naproxen
Tablet
250 mg
545024324
6 mg
Ketorolac
545021100
Acetaminophen
Tablet
500 mg
Aspirin /
acetaminophen /
caffeine
Tablet
545024325
Ergotamine
Tablet
1 mg
Dihydroergotamine
Ampoule
545034510
Chlorpromazine
Ampoule
25 mg
Prochlorperazine
208
MEDICATIONS LIST
Adult Acute Bacterial Meningitis

Code
Item
Dosage form
Strength
547054480
Dexamethasone
Ampoule
8 mg/2ml
540014370
Vancomycin
HCL
Vial
500 mg
540014250
Cefotaxim
Sodium
Vial
1 gm
540014256
Ceftriaxone
Vial
1 gm
540014248
Cefepim
Vial
1 gm
540014255
2 gm
540014253
Cefixime
Susspension
100 mg/
5 ml
540014135
Ampicillin
Sodium
Vial
500 mg
540014140
1 gm
MEDICATIONS LIST
209
Acetaminophen (Paracetamol, APAP) Overdose

Code
Item
Dosage form
Strength
551051390
Activated
Charcoal
Powder or
suspension
50-100gm/
Container
551054355
Acetylcysteine
Ampoule
200mg/10
ml
543014170
Vitamin K
(Phytomenadione)
Tablet
10 mg
543014150
Vitamin K
(Phytomenadione)
Ampoule
2 mg
543014160
Vitamin K
(Phytomenadione)
Ampoule
10 mg
543034240
Protamine
sulfate
Ampoule
1%
50mg/5ml
210
MEDICATIONS LIST
Sickle cell disease in emergency department

Code
Item
Dosage form
Strength
545024051
Morphine sulfate
Ampoule
10 mg
Hydromorphone
Ampoule
545031556
Diphenhydramine
Vial
100 mg
545034555
Promethazine
Ampoule
50 mg
545021105
Paracetamol
Vial
1 gm
Anticoagulation Emergencies
Code
Item
Dosage
form
Strength
543014160
Vitamin K (Phytomenadione)
Ampoule
10 mg
Fresh Frozen Plasma
543054315
Recombinant factor
VIIa
Vial
1 mg
543054316
Recombinant factor
VIIa
Vial
2 mg
543054317
Recombinant factor
VIIa
Vial
5 mg
Prothromben Complex Concentrate
MEDICATIONS LIST
211
Hypokalemic and Hyperkalemia Emergencies

Code
Item
Dosage form
Strength
548021455
Potassium
chloride
Tablet
600 mg (8
mmol)
548024450
Potassium
chlorid
Ampoule
15% 2mmol/ml
(10ml)
548024462
Magnesium
Sulfate
Ampoule
50% 5 ml
547064580
Human Soluble Insulin

(Regular)
Vial
100I.U/ml
(10ml)
549012030
Salbutamol
Nebulization
Solution
0.5% 20ml/bottole
548034600
Dextrose
Ampoule or
vial
50% 50 ml
Diabetic Emergencies
Code
Item
Dosage
form
Strength
548024410
Sodium Chloride (Normal Saline)
Bottle or
bag
0.9% 500
ml
548024413
Piggy bag
0.9% 100
ml
548024412
Piggy bag
0.9% 50
ml
212
MEDICATIONS LIST
547064580
Human Soluble Insulin

(Regular)
Vial
100I.U/
ml
(10ml)
548024450
Potassium chloride
Ampoule
15%
2mmol/
ml
(10ml)
548024430
Sodium Bicarbonate
Bottle Or
Bag
5% 250
ml
548024435
Sodium Bicarbonate
Prefilled
syringe
8.4%
1mEq/ml
10 ml
548024420
Sodium Bicarbonate
Prefilled
syringe
8.4%
1mEq/ml
50 ml
Sodium Phosphate
548024310
Calcium Gluconate
Ampoule
10%
10ml
548024462
Magnesium Sulfate
Ampoule
50% 5 ml
MEDICATIONS LIST
213

Code
Item
Dosage
form
Strength
547071715
Levothyroxin
sodium
Ampoule
200-500 mcg
547054405
Hydrocortisone
Ampoule or
Vial
100 mg
544051205
Propranolol
Tablet
40 mg
544051201
Propranolol
Tablet
10 mg
544054210
Propranolol
Ampoule
1 mg
547051470
Dexamethasone
Ampoule
5 mg
547071750
Propylthiouracil
Tablets
50 mg
547071760
Carbimazole
Tablets
5 mg
192000055
131 l-Iodine
therapy dose
50mci
Vial
50 mci
214
MEDICATIONS LIST
Rhabdomyolysis: Advances in Diagnosis and Treatment
Code
Item
Dosage form
Strength
548024410
Sodium Chloride (Normal

Saline)
Bottle or bag
0.9% 500 ml
548024413

Saline)
Piggy bag
0.9% 100 ml
548024412

Saline)
Piggy bag
0.9% 50 ml
Acute Urinary Retention

Code
Item
Dosage form
Strength
547011025
Finasteride
Tablet
5 mg
MEDICATIONS LIST
215
Severe Traumatic Brain Injury

Code
Item
Dosage form
Strength
544074535
Mannitol
Infusion bottle
20% 250 ml
glass bottole
545051748
Phenytoin
Sodium
Capsule
50 mg
545051750
Phenytoin
Sodium
Capsule
100 mg
545051760
Phenytoin
Sodium
Vial
250 mg
216
MEDICATIONS LIST
Refrences
Tintinallis Emergency Medicine (Emergency Medicine (Tintinalli))by David Cline, O. John Ma, Rita Cydulka and Garth Meckler.

Roberts and Hedges Clinical Procedures in Emergency

Medicine: Expert Consult - Online and Print, 6e (Roberts, by James R. Roberts MD FACEP FAAEM FACMT.
Rosens Emergency Medicine - Concepts and Clinical

Practice: Expert Consult Premium Edition - by John
Marx MD, Robert Hockberger MD and Ron Walls MD.
Emergency medicine practice evidenced-based.
Tarascon Adult Emergency Pocketbook by Dr. Steven

G. Rothrock.
MEDICATIONS LIST
217
Authors
Hattan Muhammad Bojan
Consultant Emergency Medicine
Director of Emergency Medical Services Makkah Region
General Directorate of Health Affairs Makkah Region
Makkah, Saudi Arabia
Abdul-Aziz Al-Shotairy
Director of King Saud Hospital
Ministry of Health
Jeddah, Saudi Arabia
Ayman Yousif Altirmizi
Specialist Mass Gathering Medicine
Primary Health Care
Ministry of Health
Suhail Abdullah Khabeer
Clinical Pharmacist
King Saud Hospital
Ministry of Health
218
Illustrations
Medication Table by Suhail Abdullah Khabeer
Reviewed by:
Dr. Sattam AlEnezi, MD, SBEM, ArEM, JBEM, IEM
Director of Emergency Medicine Departments, MOH
It is with great pleasure that we extend our sincere thanks and
appreciation to Dr Mohammed Okashah for his generous support
and help on this work.
219
M.O.H
DRUG LIST
ALPHAPITICAL
DRUG INDEX
MOH Pocket Manual in General Surgery

)A(
abacvir sulfate + lamivudine + zidovudine
atracurium besylate
atropine sulphate
acetazolam ide
azathioprine
acetylcholine chloride
azelaic acid
)acetyl salicylic acid (asprine
azithromycin
)B(
acitren
acyclovir
bacillus calmette-gue rin
adalimumab
bacitrin zinc + polymixin b sulphate
adefovir dipivoxil
baclofen
adenosine
basiliximab
adrenaline hcl
bcg vaccine (bacillus calmette Guer)in
)adrenaline (epinephrine
beclomethasone
albendazole
bnzhexol hcl
albumen human
benzoyl peroxide
alemtuzumab
benztropine mesylate
alendronate sodium
beractant,phospholipid
alfacalcidol
betahistine dihydrochloride
allopurinol
betamethasone
alprazolam
betaxolol hcl
alprostadil (prostaglandin e1) pediatric

dose
bevacizumab
alteplase
bicalutamide
aluminum hydroxide + magnesium

hydroxide
bimatoprost
222
ALPHAPITICAL DRUG INDEX

amantadine hcl
bisacodyl
amethocain
bisoprolol fumarate
amikacin sulfate
bleomycin
amiloride hcl + hydrochloridethiazide
bortezomib
aminoacids for adult
bosentan
aminocaproic acid
botulinum toxin type a
aminoglutethimide
bretulium tosylate
aminophyline
brimonidine tartrate
amiodarone hcl
brinzolamide
amlodipine besilate or felodephne
bromocriptine
ammonium chlorhde
b-sitosterol
amobarbitol
budesonide
amoxicilline trihydrate
budesonide 3mg capsules
amoxicilline trihydrate + clavulanate

potassium
budesonide turbuhaler
amphotericin b liposomal
Bulk-forming laxative
mpicilline sodium
bupivacaine hcl
anagrelide
buprenorphine
anastrozole
bupropion
antihemorroidal / without steroids
busulfan
)C(
)anti rabies serum (horse origin

anti-rho(d) immunogloblin
cabergoline
)antithymocyte globulin(atg
calcipotriol
apracloidine hcl
calcipotriol + betamethasone dipropionate
aripiprazole
)calcitonin (salmon)-(salcatonin
223

artemether + lumefantrine
calcitriol
artemisinin
calcium carbonate
artesunate
calcium chloride
artesunate + sulfadoxine + pyrimehamine
calcium gluconate
artificial tears eye dropper
calcium lactate
)ascorbic acid (vitamin c
capecitabine
)sparaginase (crisantaspase
capreomycine
atazanavir
captopril
atenolol
carbamazepine
atorvastatin
carbimazole
carboplatin
cyclophosphamide
carboprost tromethamine
cycloserine
carboxymethyl-cellulose
cyclosporine
carmustine
cyprotone acetate + ethinyl estradiol
carteolol hcl
cytarabine for injection

)D(
carvedilol
caspofungin acetate
dabigatran
cafaclor
dacarbazine
cefepime hydrochloride
dactinomycin
cefixime
dalteparin
cefixime sodium
danazol
ceftazidime pentahydrate
dantrolene sodium
ceftriaxone sodium
dapsone
224

cefuroxime
darunavir
celecoxib
dasatinib monohydrate
cephalexin monohydrate
daunorubicin hcl
cephradine
desmopressin acetate
cetuximab
dexamethasone
chloral hydrate
Dextran (dextran40) + sodium chlorid
chlorambcil
dextromethorphan
chloramphenicol
dextrose
chlordiazepoxide hcl
diazepam
chlorhexidine gluconate
diazoxide
chloroquine
diclofenac
chlorpheniramine maleate
didanosine
chlorpromazine hcl
diethylcarbamazine citrate
chlorthalidone
digoxin
chlorzoxazone
dihydralazine mesilate or hydralazine

hcl
)cholecalciferol (vitamine d3
diloxanide furoate
cholestyramine
)diltiazem hcl (sustainad release
cincalcet hydrochloride
dimenhydrinate
cinnararizine
dinoprostone
ciprofloxacin
diphenhydramine hcl
cispltin
)diphetheria,tetanus,pertussis (dpt
citalopam hydrobromide
diphetheria,tetanus vaccine for adult
clarithromycin
diphetheria,tetanus vaccine for

children
clindamycin
diphetheria antitoxine
225

clindamycin or erythromycin for acne
dipyridamol
clindamycin phosphate
disodium pamidronate
clofazimin
disopyramide phosphate
clomiphene citrate
distigmine bromide
clomipramine hcl
dodutamine hcl
clonazepam
docetaxel
clonidine hcl
docusate sodium
clopidogral
domperidone
clotrimazole
dopamine hcl
cloxacillin or flucloxacillin sodium
dorzolamide&1
clozapine
doxorubicin
codeine phosphate
duloxetine
colchicine
dydrogesterone
colistin sulphomethate sodium
)E(
conjugated estrogen + norgestrel
econazole
corticorelin (corticotrophin-releasing
)factor,crf
edrophonium chloride
cromoglycate sodium
efavirenz
)cyanocobalmin (vit b12
)electrolyte oral rehydration salt (ors
cyclopentolate hcl
emtricitabine
cyclophosphamide
carboplatin
cycloserine
carboprost tromethamine
cyclosporine
carboxymethyl-cellulose
cyprotone acetate + ethinyl estradiol
carmustine
cytarabine for injection
carteolol hcl
226

(D)
carvedilol
dabigatran
caspofungin acetate
dacarbazine
cafaclor
dactinomycin
cefepime hydrochloride
dalteparin
cefixime
danazol
cefixime sodium
dantrolene sodium
ceftazidime pentahydrate
dapsone
ceftriaxone sodium
darunavir
cefuroxime
dasatinib monohydrate
celecoxib
daunorubicin hcl
cephalexin monohydrate
desmopressin acetate
cephradine
dexamethasone
cetuximab
Dextran (dextran40) + sodium chlorid
chloral hydrate
dextromethorphan
chlorambcil
dextrose
chloramphenicol
diazepam
chlordiazepoxide hcl
diazoxide
chlorhexidine gluconate
diclofenac
chloroquine
didanosine
chlorpheniramine maleate
diethylcarbamazine citrate
chlorpromazine hcl
digoxin
chlorthalidone
dihydralazine mesilate or hydralazine

hcl
chlorzoxazone
227

diloxanide furoate
cholecalciferol (vitamine d3)
diltiazem hcl (sustainad release)
cholestyramine
dimenhydrinate
cincalcet hydrochloride
dinoprostone
cinnararizine
diphenhydramine hcl
ciprofloxacin
diphetheria,tetanus,pertussis (dpt)
cispltin
diphetheria,tetanus vaccine for adult
citalopam hydrobromide
diphetheria,tetanus vaccine for children
clarithromycin
diphetheria antitoxine
clindamycin
dipyridamol
clindamycin or erythromycin for acne
disodium pamidronate
clindamycin phosphate
disopyramide phosphate
clofazimin
distigmine bromide
clomiphene citrate
dodutamine hcl
clomipramine hcl
docetaxel
clonazepam
docusate sodium
clonidine hcl
domperidone
clopidogral
dopamine hcl
clotrimazole
dorzolamide&1
cloxacillin or flucloxacillin sodium
doxorubicin
clozapine
duloxetine
codeine phosphate
dydrogesterone
colchicine
(E)
econazole
228
colistin sulphomethate sodium

conjugated estrogen + norgestrel

edrophonium chloride
corticorelin
factor,crf)
efavirenz
cromoglycate sodium
electrolyte oral rehydration salt (ors)
cyanocobalmin (vit b12)
emtricitabine
cyclopentolate hcl
enalapril malate
Gemfibrozil
enfuvirtide
gentamicine
enoxaparin
glibenclamide
entecvir
gliclazide
ephedrine hydrochloride
glipizide
epirubicin hcl
glucagon
epoetin (recombinant human eryth)ropoietins
(corticotrophin-releasing
glycrine
ergotamine tartarate
glycopyrrolate bromide
erlotinib hydrochloride
gonadorelin (gonadotrophine-releas)ing hormone, lhrh
erythromycin
goserlin acetate
escitalopram
granisetron
esmolol hcl
griseofulvin micronized
esomeprazole magnesium trihydrate
)H(
estradiol valerate
haemophilus influenza vaccine
etanercept
haloperidol
ethambutol hcl
heparinecalcium for subcutaneous

injection
ethanolamine oleate
)heparine sodium (bovine
ethinyl estradiol
)hepatitis b vaccine (child
ethionamide
homatropine
229

ethosuximide
human chorionic gonadotrophin
etomidate
human fibrinogen
etoposide
)human isophane insulin (nph
etravirine
human menopausal gonadotrophins,follicle
)F(
stimulating hormone + luteinizing

hormone
factor ix fraction for injection, which

is sterile and free of hepatitis, hivand
any other infectious disease agent
human normal immunoglobulin for

i.m injection
factor viii (stable lyophilized con)centrate
)human soluble insulin (regular
fat emulsion
hyaluronidase
)felodipine retard (modified release
hydralazine hcimesilate
fentanyl citrate
hydrochlorothiazide
ferrous salt
hydrocortisone
ferrous sulphate or fumarate + folic

acid
hydroxurea
filgrastim g-csf
hydroxychloroquine sulphate
finasteride
ydroxyprogesterone hexanoate
fluconazole
hydroxypropyl methylcelulose
fludarabine phoaphate
hyocine butylbromide
fludrocortisones acetate
)I(
flumazenil
ibuprofen
fluorescein
ifosfamide
fluorometholone
iloprost
fluorouracil
imatinib mesilate
230

fluoxetine
imidazole derivative
flupenthixol
imipenem + cilastatin
fluphenazine decanoate
imipramine hcl
flutamide
)indapamide (sustaind release
fluticasone
indinavir
fluvoxamine malate
indomethacin
follitropin
infliximab
formoterol + budesonide turbuhaler
influenza virus vaccine
foscarnet
injectable polio vaccines (ipv) (salk

)vaccine
fosinopril
insulin aspart
furosemide
nsulin detmir
fusidic acid
insulin glargine
)G(
insulin lispro
gabapentine
interferon alpha
ganciclovir
interferon beta 1a
gemcitabine
ipratropium bromide
medroxyprogesterone acetate
irbesartan
mefenemic acid
irintecan hydrochloride
melfloquine hcl
iron saccharate
megestrol acetate
isoniazid
meloxicam
isoprenaline hcl (isoproterenol hcl)
melphalan
isosorbide dinitrate
memantine hcl
231

meningococcal polysaccharide sero
group (a,c,y,w-135)
isotretinoin
mercaptopurine
itraconazole
meropenem
ivabradine
mesalazine
ivermectin
(K)
mesna
metformin hcl
kanamycin
methadone hcl
kaolin + pectin
methotrexate
ketamine hcl
methoxsalen + ammidine
ketoconazole
methoxy polyethylene glycol-epoetin

beta
ketotifen
(L)
methyldopa
methylerrgonovine maleate
labetalol hcl
methylphenidate
lactulose
methylperdnisolone
lamivudine
metoclopramide hcl
lamotrigine
metolazone tartrate
lansoprazole
metolazone
latanoprost
metolazone tartrate
l-carnitine
etronidazole
leflunomide
mexiletine hcl
lenalidomide
micafungin sodium
letrozole
miconazole
Leucovorin calcium
midazolam
leuprolid depo acetate
miltefosine
levamizole
232

minocycline hcl
levetiracetam
mirtazapine
levofaoxacin
misoprostol
levothyroxine sodium
mitomycin
lidocaine + fluorescein sodium
mitoxantrone hydrochloride
Lidocaine hcl
mixed gas gangrene antitoxin
linezolid
moclopemide
liquid paraffin
mometasone furoate
lisinopril
montelukast sodium
lithium carbonate
orphine sulphate
lomustine
moxifloxacin hydrochloride
Loperamide hcl
ultienzyme (pancreatic enzymes:protease200-600u;lipse5,000-10,000u

and amylase5,000-10,000u) /capsule
or enteric coated tablet
lopinavir + ritonavir
multivitamins
lorazepam
mupirocin
losartan potassium
muromonab-cd3
lubricant
mycophenolate mofetil
(N)
(M)
magnesium oxide
nafarelin
mannitol
nalbuphine hcl
maprotilline hcl
naloxone hcl
measles vaccine
naphazoline
mebendazole
Naproxene
mebeverine hcl
natalizumab
mechlorethamine hcl
natamycin
meclozine + vitamine B6
233

phenylephrine hcl
nateglinide
phenytoin sodium
nelfinavir
phosphate enema
neomycin sulphate
phosphate salt
neostigmine methylsulpfate
phytomenadione
niclosamide
pilocarpine
nicotine(24-hour effect dose)
pioglitazone
nifedipine retard (modified release)
piperacillin + tazobactam
nilotinib
plasma protein solution
nimodipine
pneumococcal polyvalent (23 valent)

vaccine
nitrazepam
poliomyelitis vaccine live oral: (sabin

strain)
nitrofurantoin
polyacrylic acid
nitroglycerin
polyethylene glycol,3350-13.125g
oral ppowder, sodium bicarbonate
178.5mg,sodium chloride350mg ,
potassium chloride 46.6mg/sachet
polymyxin b sulphate + neomycin

sulphate + hydrocortisone
non sedating antihistamine tablet

(cetirizine or noratadine)
polystyrene sulphate resins (calcium)|
noradenalin acid tartrate
potassium salt
norethisterone
pramipexole
norfloxacin
pravastatin
nystatin
praziquantel
(O)
prazosin hcl
octreotide
prednisolone
ofloxacin
234

pregabalin
oily phenol injection
Prilocaine + felypressin
olanzapine
Primaquine phosphate
olopatadine hcl
Primidone
omeprazole sodium
Procainamide hcl
ondansetron
Procarbazine
orienograstim (g-csf)
Procyclidine hydrochloride
oxaliplatin
Progesterone
oxybuprocaine
Proguanil hcl
oxybutynin hcl xl
Promethazine hcl
oxymetazoline
proparacaine
oxytocin
propfol
(P)
propylthiouracil
paclitaxel
Propranolol hcl
paliperidone
Protamine sulfate
palivizumab
prothionmide
pancuronium bromide
Protirelin (thyrotrpphin-releasing
hormone,trh)
pantoprazoole sodium sesquihydrate
Pseudoephedrine hcl 30mg + antihistamine
papaverin
Pumactant phospholipid
para-amino salicylate sodium
Pura aluminum hydroxide
paracetamol
Pyrazinamide
pegaspargase
Pyrethrins
pegylated interferon alpha 2a
Pyridostigmine
pemetrexed
Pyridoxine hcl (vitamine b6)
penicillamine
235

Pyrimethamine
penicillin benzathine (penicillin g)
Prilocaine + felypressin
pentamidine isethionate
primaquine phosphate
pentavalent vacc.(hbv+hib+dtp)
(Q)
pentoxifylline
quetiapine
perindopril
quinidine sulfate
permethrin
quinine dihydrochloride
pethidine hcl
quinie sulphate
phenobarbital (phenobarbitone)
(R)
phenoxymethyl penicillin (penicillin

v potassium)
rabies immunoglobulin for i.m

injection
phentolamine mesylate
stibogluconate sodium (organic

pentavalent antimony)
rabies virus vaccine
streptokinase
racemic epinphrine
streptomycin sulfate
raltegravir
strontium ranelate
ranitidine
succinylcholine choloride
rasburicase
sucralfate
recombinant factor via
sulfacetamide
repaglinide
sulfadiazine
reteplase
sulfadoxin500mg + pyrimethamine25mg
retinoin (vitamine a)
sulfasalazine,500mg/tablet
ribavirin
sulindac
rifabutine
sulpiride
rifampicin
sumatriptan succinate
riluzole
236

(T)
ringers lactate solution
tacrolimus
risperidone
tamoxifen citrate
ritonavir
tamsulosin hcl (modified release)
rituximab
telmisartan
rivaroxaban
temazepam
rocuronium bromide
tenofovir disoproxil fumurate
ropivacaine hcl
terbinafine
rose bengal
teriparatide
rosuvastatin
terlipressin acetate
(S)
tetanus antitoxin
salbutamol
tetanus immunoglobulin for i.m

injection
salmeterol + fluticasone propionate
tetanus vaccine
scorpion anti venin
tetracosactrin (corticotrophin)
selegiline hcl
tetracycline hcl
senna
thalidomide
sevelamer
theophylline
sevoflurance
thiacetazone
sildenafil
thiamine (vitamine b1)
silver sulfadiazine (steril)
thioguanine
simethicone
thiopental sodium
simvastatin
tigecycline
sirolimus
timolol
sitagliptin phosphate
tinzaparin sodium
snake anti-venin
237

tiotropium
sodium acetate
tirofiban hydrochloride
sodium aurothiomalate
tobramycin + dexamethasone
sodium bicarbonate
tobramycin sulfate
sodium chloride
tolterodine tartrate
sodium cormoglycate
topiramate
sodium hyaluronate
trace elements additive (pediatric

dose)
sodium hyaluronate intra-articular

(mw over 3 sillion)
tramadol hcl
sodium nitropruprusside
tranexamic acid
sodium phosphate
trastuzumab
sodium valpproate
trazodone
somatropin (human growth hormone)
tretinoin
sorafenib
triamcinoloneacetonide
sotalol hydrochloride
triamterene + hydrochlorthiazide
spectinomycin hcl
trifluperazine hcl
spiramycin
trifluridine
spironolactone
trimetazidine dihydrochloride (modified release)
sterile balanced salt solution (bss)
trimethoprim + sulfamethoxazole
sterile water for injection
triple virus vaccine (measles-mumps-rubella)
verapamil hcl
triptorelin acetate
verapamil hcl (sustaind release)
tropicamide
vigabatrin
tuberculin ppd skin test
vinblastine sulfate
238

typhoid vaccine
(W)
(U)
warfarin sodium
urea
water for injection (sterile)
urofollitrophine f.s.h
wax removal
ursodeoxycholic acid
(V)
(X)
xylometazoline hcl
valaciclovir hcl
(Y)
valganciclover hcl
yellow fever vaccine
valsartan
(Z)
vancomycin hcl
zidovudine (azidothymidine,AZT)
varicella-zoster virus (chicken pox

vaccine)
zidovudine + lamivudine
vasopressine
zinc sulfate
vecuronium bromide
zolledronic acid
venlaxine hcl (sustaind release)
zolpedem tartrate
vincristine sulfate
zuclopenthixol acetate
vinorelbine
vitamine B1 & B6& B12
vitamine B complex
vitamine E
voriconazole
239
Authors
Khalid O. Dhafar, MD, MBA, FRCS, FACS
Consultant General Surgery
Health Affair, Ministry of Health
Hassan Adnan Bukhari, MD, FRCSC
Assistant Professor, General Surgery, Umm Al-Qura University
Consultant General Surgery, Trauma Surgery and Critical Care, King
Abdulaziz Hospital, Makkah, Saudi Arabia
Head of Accident and Emergency Department, Al-Noor Specialist
Hospital
Abdullah Mosleh Alkhuzaie, MD, SBGS
King Abdulaziz Hospital
Ministry of Health
Saad A. Al Awwad, MD, SBGS, JBGS
King Fahad General Hospital, Ministry of Health
240

Ali Abdullah S. Al-Zahrani, MD, SBGS
King Faisal Hospital, Ministry of Health
Taif, Saudi Arabia
Mohammed Abdulwahab Felimban, MD, ABFM, FFCM (KFU)
Director of healthcare quality and patient safety
Health affair, Ministry of Health
Faisal Ahmed Al-Wdani, BPharma (KFH)
Clinical Pharmacist
King Faisal Hospital, Ministry of Health
Illustration
Flowchart by Hassan Adnan Bukhari
Medication Table by Faisal Ahmed Al-Wdani
241
Acknowledgement
Great appreciation for Dr. Ghiath Al Sayed , Consultant General
Surgery,King Fahad medical city, for reviewing and editing this
book.

MOH Pocket Manual in Emergency Medicine

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

MOH Pocket Manual in Emergency Medicine

Uploaded by

Copyright:

Available Formats

MOH Pocket Manual in

MOH Pocket Manual in Emergency

MOH Pocket Manual in Emergency

MOH Pocket Manual in Emergency

Thyroid Storm and Myxedema Coma

MOH Pocket Manual in Emergency

MOH Pocket Manual in Emergency

MOH Pocket Manual in Emergency

Acute ST Elevation and Non

ST elevation acute myocardial infarction

NonST-segment elevation acute myocardial infarction

Unstable angina (UA).

Acute ST elevation myocardial infarction typically occurs when

MOH Pocket Manual in Emergency

Jaw/shoulder/ neck/arm pain.

Exclusion of noncardiac and nonischemic cardiac

MOH Pocket Manual in Emergency

MOH Pocket Manual in Emergency

1. The person who initiated EMS involvement (patient, family,

MOH Pocket Manual in Emergency

6. The patients code status (if known).

Assess and stabilize airway, breathing, and circulation.

Provide oxygen; attach cardiac and oxygen saturation

Treat arrhythmia rapidly according to ACLS protocols.

Give aspirin 162 to 325 mg (non-enteric coated), to be

Give three sublingual nitroglycerin tablets (0.4 mg) one

Give morphine sulfate (2 to 4 mg slow IV push every 5

MOH Pocket Manual in Emergency

Select reperfusion strategy:

Primary percutaneous coronary intervention (PCI)

Treat with fibrinolysis if PCI unavailable within 90-120

Give antiplatelet therapy (in addition to aspirin) to all

Give anticoagulant therapy to all patients:

MOH Pocket Manual in Emergency

of 50 to 70 units/kg up to a maximum of 5000 units.

In hospital care for NSTEMI:

:Early invasive1. Discuss with cardiology.

MOH Pocket Manual in Emergency

Sudden onset of severe pain.

Occurring during exercise.

Lasting longer than 15 minutes.

Associated with shortness of breath.

Nausea/vomiting and sweating.

Radiation to left arm or jaw.

In case of inferior myocardial infarction , you must do

MOH Pocket Manual in Emergency

Atrial Fibrillation: Management Strategies

Conduction system disorders.

Conditions associated with AF include:

Intrathoracic surgery, such as cardiac or pulmonary

MOH Pocket Manual in Emergency

Atrial Fibrillation is categorized as follows:

First detected episode.

Recurrent (after two or more episodes).

Paroxysmal (if recurrent AF terminates spontaneously).

Persistent (if sustained beyond 7 days).

Medications and alcohol and drug use.

Evidence of thyroid disease (eg, exophthalmos and enlarged thyroid).

Evidence of deep vein thrombosis/pulmonary embolus

The cardiac evaluation: rate, rhythm, and the presence

MOH Pocket Manual in Emergency

MOH Pocket Manual in Emergency

Complete blood cell count.

Hepatic function panel.